BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O’Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7:pii: e1000348. [PMID: 20957191 DOI: 10.1371/journal.pmed.1000348] [Cited by in Crossref: 333] [Cited by in F6Publishing: 316] [Article Influence: 30.3] [Reference Citation Analysis]
Number Citing Articles
1 Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS. Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med 2009;7:47. [PMID: 19751516 DOI: 10.1186/1741-7015-7-47] [Cited by in Crossref: 121] [Cited by in F6Publishing: 101] [Article Influence: 10.1] [Reference Citation Analysis]
2 Grijalva CG, Pelton SI. A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children. Curr Opin Pediatr 2011;23:98-104. [PMID: 21191300 DOI: 10.1097/MOP.0b013e328341d1f5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
3 Shen M, Yao R, Yue H, Zhang J, Chen M, Zhang W, Liu D, Wu K. Serotype prevalence and antibiotic susceptibility patterns of pneumococcal isolates in Zunyi city, China. Saudi Med J 2017;38:1243-9. [PMID: 29209675 DOI: 10.15537/smj.2017.12.21090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Varghese R, Neeravi A, Subramanian N, Pavithra B, Kavipriya A, Kumar JL, Girish Kumar CP, Jeyraman Y, Karthik G, Verghese VP, Veeraraghavan B. Clonal similarities and sequence-type diversity of invasive and carriage Streptococcus pneumoniae in India among children under 5 Years. Indian J Med Microbiol 2019;37:358-62. [PMID: 32003333 DOI: 10.4103/ijmm.IJMM_19_348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Toor J, Echeverria-Londono S, Li X, Abbas K, Carter ED, Clapham HE, Clark A, de Villiers MJ, Eilertson K, Ferrari M, Gamkrelidze I, Hallett TB, Hinsley WR, Hogan D, Huber JH, Jackson ML, Jean K, Jit M, Karachaliou A, Klepac P, Kraay A, Lessler J, Li X, Lopman BA, Mengistu T, Metcalf CJE, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Razavi H, Razavi-Shearer D, Resch S, Sanderson C, Sweet S, Tam Y, Tanvir H, Tran Minh Q, Trotter CL, Truelove SA, Vynnycky E, Walker N, Winter A, Woodruff K, Ferguson NM, Gaythorpe KA. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. Elife 2021;10:e67635. [PMID: 34253291 DOI: 10.7554/eLife.67635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Goulenok T. Vaccination anti-pneumococcique chez l’adulte : comment améliorer la couverture vaccinale ? Journal des Anti-infectieux 2014;16:89-98. [DOI: 10.1016/j.antinf.2014.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Tempia S, Wolter N, Cohen C, Walaza S, von Mollendorf C, Cohen AL, Moyes J, de Gouveia L, Nzenze S, Treurnicht F, Venter M, Groome MJ, Madhi SA, von Gottberg A. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis 2015;15:450. [PMID: 26496761 DOI: 10.1186/s12879-015-1198-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
8 Mészner Z. [Pneumococcal disease prevention from early infancy to old age]. Orv Hetil 2014;155:243-7. [PMID: 24509352 DOI: 10.1556/OH.2014.29753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Moïsi JC, Makawa MS, Tall H, Agbenoko K, Njanpop-Lafourcade BM, Tamekloe S, Amidou M, Mueller JE, Gessner BD. Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine. PLoS One 2017;12:e0170412. [PMID: 28114427 DOI: 10.1371/journal.pone.0170412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Castañeda E, Agudelo CI, De Antonio R, Rosselli D, Calderón C, Ortega-Barria E, Colindres RE. Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010. BMC Infect Dis 2012;12:124. [PMID: 22639955 DOI: 10.1186/1471-2334-12-124] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
11 Rodrigo C, Lim WS. The Relevance of Pneumococcal Serotypes. Curr Infect Dis Rep 2014;16. [DOI: 10.1007/s11908-014-0403-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
12 Narwortey DK, Owusu-Ofori A, Slotved HC, Donkor ES, Ansah PO, Welaga P, Agongo G, Oduro AR. Nasopharyngeal carriage of Streptococcus pneumoniae among healthy children in Kassena-Nankana districts of Northern Ghana. BMC Infect Dis 2021;21:661. [PMID: 34233627 DOI: 10.1186/s12879-021-06302-5] [Reference Citation Analysis]
13 Prymula R, Chlibek R, Ivaskeviciene I, Mangarov A, Mészner Z, Perenovska P, Richter D, Salman N, Šimurka P, Tamm E, Tešović G, Urbancikova I, Usonis V. Paediatric pneumococcal disease in Central Europe. Eur J Clin Microbiol Infect Dis 2011;30:1311-20. [DOI: 10.1007/s10096-011-1241-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
14 Moore DP, Dagan R, Madhi SA. Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination. Expert Rev Respir Med 2012;6:451-65. [PMID: 22971069 DOI: 10.1586/ers.12.32] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
15 Voysey M, Pollard AJ, Perera R, Shrestha S, Thorson S, Fanshawe TR. Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences. PLoS One 2018;13:e0196200. [PMID: 29702658 DOI: 10.1371/journal.pone.0196200] [Reference Citation Analysis]
16 Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS One 2017;12:e0177113. [PMID: 28486544 DOI: 10.1371/journal.pone.0177113] [Cited by in Crossref: 164] [Cited by in F6Publishing: 134] [Article Influence: 41.0] [Reference Citation Analysis]
17 Nagaraj G, Govindan V, Ganaie F, Venkatesha VT, Hawkins PA, Gladstone RA, McGee L, Breiman RF, Bentley SD, Klugman KP, Lo SW, Ravikumar KL. Streptococcus pneumoniae genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach. Microb Genom 2021;7. [PMID: 34494953 DOI: 10.1099/mgen.0.000645] [Reference Citation Analysis]
18 Visan L, Rouleau N, Proust E, Peyrot L, Donadieu A, Ochs M. Antibodies to PcpA and PhtD protect mice against Streptococcus pneumoniae by a macrophage- and complement-dependent mechanism. Hum Vaccin Immunother 2018;14:489-94. [PMID: 29135332 DOI: 10.1080/21645515.2017.1403698] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
19 Madhi SA, Koen A, Jose L, Moreira M, van Niekerk N, Cutland C, François N, Ruiz-Guiñazú J, Yarzabal JP, Borys D, Schuerman L. Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial. Expert Rev Vaccines 2017;16:641-56. [PMID: 28425818 DOI: 10.1080/14760584.2017.1321990] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
20 Nisar MI, Ahmed S, Jehan F, Shahid S, Shakoor S, Kabir F, Hotwani A, Munir S, Muhammad S, Khalid F, Althouse B, Hu H, Whitney C, Ali A, Zaidi AKM, Omer SB, Iqbal N. Direct and indirect effect of 10 valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years of age in Matiari, Pakistan. Vaccine 2021;39:1319-27. [PMID: 33422379 DOI: 10.1016/j.vaccine.2020.12.066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Megiddo I, Klein E, Laxminarayan R. Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India. BMJ Glob Health 2018;3:e000636. [PMID: 29765775 DOI: 10.1136/bmjgh-2017-000636] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
22 Chapman R, Sutton K, Dillon-Murphy D, Patel S, Hilton B, Farkouh R, Wasserman M. Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Vaccine 2020;38:7138-45. [PMID: 32912642 DOI: 10.1016/j.vaccine.2020.08.068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
23 Nagaraj G, Ganaie F, Govindan V, Ravikumar KL. Development of PCRSeqTyping-a novel molecular assay for typing of Streptococcus pneumoniae. Pneumonia (Nathan) 2017;9:8. [PMID: 28702310 DOI: 10.1186/s41479-017-0032-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
24 Vorobieva S Jensen V, Furberg AS, Slotved HC, Bazhukova T, Haldorsen B, Caugant DA, Sundsfjord A, Valentiner-Branth P, Simonsen GS. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines. BMC Infect Dis 2020;20:279. [PMID: 32293324 DOI: 10.1186/s12879-020-04998-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Dicko A, Santara G, Mahamar A, Sidibe Y, Barry A, Dicko Y, Diallo A, Dolo A, Doumbo O, Shafi F, François N, Strezova A, Borys D, Schuerman L. Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children. Hum Vaccin Immunother 2013;9:382-8. [PMID: 23291945 DOI: 10.4161/hv.22692] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
26 Gonzales-Siles L, Salvà-Serra F, Degerman A, Nordén R, Lindh M, Skovbjerg S, Moore ERB. Identification and capsular serotype sequetyping of Streptococcus pneumoniae strains. J Med Microbiol 2019;68:1173-88. [PMID: 31268417 DOI: 10.1099/jmm.0.001022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Alizadeh Chamkhaleh M, Esteghamati A, Sayyahfar S, Gandomi-Mohammadabadi A, Balasi J, Abdiaei H, Moradi Y, Moradi-Lakeh M. Serotype distribution of Streptococcus pneumoniae among healthy carriers and clinical patients: a systematic review from Iran. Eur J Clin Microbiol Infect Dis 2020;39:2257-67. [PMID: 32601893 DOI: 10.1007/s10096-020-03963-z] [Reference Citation Analysis]
28 Almazrou Y, Shibl AM, Alkhlaif R, Pirçon JY, Anis S, Kandeil W, Hausdorff WP. Epidemiology of invasive pneumococcal disease in Saudi Arabian children younger than 5years of age. J Epidemiol Glob Health 2016;6:95-104. [PMID: 26368823 DOI: 10.1016/j.jegh.2015.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
29 Coskun-Ari FF, Guldemir D, Durmaz R. One-step multiplex PCR assay for detecting Streptococcus pneumoniae serogroups/types covered by 13-valent pneumococcal conjugate vaccine (PCV13). PLoS One 2012;7:e50406. [PMID: 23226519 DOI: 10.1371/journal.pone.0050406] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
30 Mirsaeidi M, Ebrahimi G, Allen MB, Aliberti S. Pneumococcal vaccine and patients with pulmonary diseases. Am J Med 2014;127:886.e1-8. [PMID: 24852934 DOI: 10.1016/j.amjmed.2014.05.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
31 Ngocho JS, Magoma B, Olomi GA, Mahande MJ, Msuya SE, de Jonge MI, Mmbaga BT. Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review. PLoS One 2019;14:e0212295. [PMID: 30779801 DOI: 10.1371/journal.pone.0212295] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
32 Lee J, Yoon Y, Kim EJ, Lee D, Baek Y, Takano C, Chang B, Iijima T, Kilgore PE, Hayakawa S, Hoshino T, Kim DW, Seki M. 23-valent polysaccharide vaccine (PPSV23)-targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated isothermal amplification (LAMP) method. PLoS One 2021;16:e0246699. [PMID: 33591996 DOI: 10.1371/journal.pone.0246699] [Reference Citation Analysis]
33 Tokarz R, Briese T, Morris G, Ideh R, Chimah O, Ebruke B, Desai A, Haq S, Sameroff S, Howie SR, Lipkin WI. Serotype analysis of Streptococcus pneumoniae in lung and nasopharyngeal aspirates from children in the Gambia by MassTag PCR. J Clin Microbiol 2013;51:995-7. [PMID: 23254132 DOI: 10.1128/JCM.02974-12] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Gupta A, Mathad JS, Yang WT, Singh HK, Gupte N, Mave V, Bharadwaj R, Zaman K, Roy E, Bollinger RC, Bhosale R, Steinhoff MC. Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs. Vaccine 2014;32:1466-72. [PMID: 24486350 DOI: 10.1016/j.vaccine.2014.01.033] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
35 Walsh RL, Camilli A. Streptococcus pneumoniae is desiccation tolerant and infectious upon rehydration. mBio 2011;2:e00092-11. [PMID: 21610120 DOI: 10.1128/mBio.00092-11] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
36 Midouni B, Mehiri E, Ghariani A, Draoui H, Essalah L, Bouzouita I, Raoult D, Slim-saidi L, Fournier P. Genetic diversity of Streptococcus pneumoniae in Tunisia. International Journal of Antimicrobial Agents 2019;53:63-9. [DOI: 10.1016/j.ijantimicag.2018.09.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Adegbola RA, DeAntonio R, Hill PC, Roca A, Usuf E, Hoet B, Greenwood BM. Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS One 2014;9:e103293. [PMID: 25084351 DOI: 10.1371/journal.pone.0103293] [Cited by in Crossref: 101] [Cited by in F6Publishing: 87] [Article Influence: 14.4] [Reference Citation Analysis]
38 Bosch AATM, van Houten MA, Bruin JP, Wijmenga-Monsuur AJ, Trzciński K, Bogaert D, Rots NY, Sanders EAM. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands. Vaccine 2016;34:531-9. [PMID: 26667610 DOI: 10.1016/j.vaccine.2015.11.060] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
39 Sakata H. Invasive Streptococcus pneumoniae infections in children in Kamikawa and Soya subprefecture, Hokkaido, Japan, 2000–2010, before the introduction of the 7-valent pneumococcal conjugate vaccine. Journal of Infection and Chemotherapy 2011;17:799-802. [DOI: 10.1007/s10156-011-0264-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
40 Bloom DE, Kirby PN, Pugh S, Stawasz A. Commentary: Why Has Uptake of Pneumococcal Vaccines for Children Been So Slow? The Perils of Undervaluation. Pediatric Infectious Disease Journal 2020;39:145-56. [DOI: 10.1097/inf.0000000000002521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
41 Tinoco JC, Juergens C, Ruiz Palacios GM, Vazquez-Narvaez J, Enkerlin-Pauwells HL, Sundaraiyer V, Pathirana S, Kalinina E, Gruber WC, Scott DA, Schmoele-Thoma B. Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico. Clin Vaccine Immunol 2015;22:185-92. [PMID: 25499011 DOI: 10.1128/CVI.00711-14] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
42 Madhi SA, Izu A, Violari A, Cotton MF, Panchia R, Dobbels E, Sewraj P, van Niekerk N, Jean-Philippe P, Adrian PV; CIPRA-4 team. Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants. Vaccine 2013;31:777-83. [PMID: 23228814 DOI: 10.1016/j.vaccine.2012.11.076] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
43 Evans BA, Rozen DE. A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella. Eur J Clin Microbiol Infect Dis 2012;31:2653-60. [PMID: 22466968 DOI: 10.1007/s10096-012-1609-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
44 Pan F, Han L, Huang W, Tang J, Xiao S, Wang C, Qin H, Zhang H. Serotype Distribution, Antimicrobial Susceptibility, and Molecular Epidemiology of Streptococcus pneumoniae Isolated from Children in Shanghai, China. PLoS One 2015;10:e0142892. [PMID: 26571373 DOI: 10.1371/journal.pone.0142892] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
45 Lai JY, Cook H, Yip TW, Berthelsen J, Gourley S, Krause V, Smith H, Leach AJ, Smith-Vaughan H. Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010-2012. BMC Infect Dis 2013;13:409. [PMID: 24138669 DOI: 10.1186/1471-2334-13-409] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
46 Odutola A, Ota MOC, Antonio M, Ogundare EO, Saidu Y, Owiafe PK, Worwui A, Idoko OT, Owolabi O, Kampmann B, Greenwood BM, Alderson M, Traskine M, Swinnen K, Verlant V, Dobbelaere K, Borys D. Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants. Vaccine 2019;37:2586-99. [PMID: 30975570 DOI: 10.1016/j.vaccine.2019.03.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
47 Hampton LM, Zell ER, Schrag S, Cohen AL. Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. Bull World Health Organ 2012;90:568-77. [PMID: 22893740 DOI: 10.2471/BLT.11.098178] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
48 Souza TH, Nadal JA, Lopes CE, Nogueira RJN. ASSOCIATION OF MENINGITIS AND PERICARDITIS IN INVASIVE PNEUMOCOCCAL DISEASE: A RARE CASE. Rev Paul Pediatr 2019;37:126-9. [PMID: 30183802 DOI: 10.1590/1984-0462/;2019;37;1;00009] [Reference Citation Analysis]
49 Gatera M, Uwimana J, Manzi E, Ngabo F, Nwaigwe F, Gessner BD, Moïsi JC. Use of administrative records to assess pneumococcal conjugate vaccine impact on pediatric meningitis and pneumonia hospitalizations in Rwanda. Vaccine 2016;34:5321-8. [PMID: 27639280 DOI: 10.1016/j.vaccine.2016.08.084] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
50 Olaya-Abril A, González-Reyes JA, Rodríguez-Ortega MJ. Approaching In Vivo Models of Pneumococcus-Host Interaction: Insights into Surface Proteins, Capsule Production, and Extracellular Vesicles. Pathogens 2021;10:1098. [PMID: 34578131 DOI: 10.3390/pathogens10091098] [Reference Citation Analysis]
51 Ramdani-Bouguessa N, Ziane H, Bekhoucha S, Guechi Z, Azzam A, Touati D, Naim M, Azrou S, Hamidi M, Mertani A, Laraba A, Annane T, Kermani S, Tazir M. Evolution of antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolated from children with invasive and noninvasive pneumococcal diseases in Algeria from 2005 to 2012. New Microbes New Infect 2015;6:42-8. [PMID: 26106481 DOI: 10.1016/j.nmni.2015.02.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
52 Kobayashi M, Conklin LM, Bigogo G, Jagero G, Hampton L, Fleming-Dutra KE, Junghae M, Carvalho MD, Pimenta F, Beall B, Taylor T, Laserson KF, Vulule J, Van Beneden C, Kim L, Feikin DR, Whitney CG, Breiman RF. Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010. BMC Infect Dis 2017;17:25. [PMID: 28056828 DOI: 10.1186/s12879-016-2103-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
53 Ndlangisa KM, du Plessis M, Allam M, Wolter N, Mohale T, de Gouveia L, Birkhead M, Klugman KP, von Gottberg A. Two cases of serotypeable and non-serotypeable variants of Streptococcus pneumoniae detected simultaneously during invasive disease. BMC Microbiol 2016;16:126. [PMID: 27342074 DOI: 10.1186/s12866-016-0745-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
54 Chaguza C, Senghore M, Bojang E, Lo SW, Ebruke C, Gladstone RA, Tientcheu PE, Bancroft RE, Worwui A, Foster-Nyarko E, Ceesay F, Okoi C, McGee L, Klugman KP, Breiman RF, Barer MR, Adegbola RA, Antonio M, Bentley SD, Kwambana-Adams BA. Carriage Dynamics of Pneumococcal Serotypes in Naturally Colonized Infants in a Rural African Setting During the First Year of Life. Front Pediatr 2020;8:587730. [PMID: 33489998 DOI: 10.3389/fped.2020.587730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Johansson KA, Memirie ST, Pecenka C, Jamison DT, Verguet S. Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis. PLoS One 2015;10:e0142691. [PMID: 26650078 DOI: 10.1371/journal.pone.0142691] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
56 Karami M, Hosseini SM, Hashemi SH, Ghiasvand S, Zarei O, Safari N, Erfani H, Alikhani MY. Prevalence of nasopharyngeal carriage of Streptococcus pneumoniae in children 7 to 14 years in 2016: A survey before pneumococcal conjugate vaccine introduction in Iran. Hum Vaccin Immunother 2019;15:2178-82. [PMID: 31267848 DOI: 10.1080/21645515.2018.1539601] [Reference Citation Analysis]
57 Sharew B, Moges F, Yismaw G, Mihret A, Abebe W, Fentaw S, Tessema B. Serotype Distribution of Streptococcus pneumoniae Isolates Causing Invasive and Non-Invasive Infections Using Whole-Genome Sequencing in Ethiopia. Infect Drug Resist 2021;14:787-94. [PMID: 33688213 DOI: 10.2147/IDR.S293578] [Reference Citation Analysis]
58 Marthos BV, Ferri ALS, de Figueiredo DB, Zangirolami TC, Gonçalves VM. Capsular polysaccharide production by Streptococcus pneumoniae serotype 1: from strain selection to fed-batch cultivation. Appl Microbiol Biotechnol 2015;99:10447-56. [DOI: 10.1007/s00253-015-6928-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
59 Ceyhan M, Ozsurekci Y, Gürler N, Öksüz L, Aydemir S, Ozkan S, Yuksekkaya S, Keser Emiroglu M, Gültekin M, Yaman A, Kiremitci A, Yanık K, Karli A, Ozcinar H, Aydin F, Bayramoglu G, Zer Y, Gulay Z, Gayyurhan ED, Gül M, Özakın C, Güdücüoğlu H, Perçin D, Akpolat N, Ozturk C, Camcıoğlu Y, Karadağ Öncel E, Çelik M, Şanal L, Uslu H. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014. Hum Vaccin Immunother 2016;12:308-13. [PMID: 26325175 DOI: 10.1080/21645515.2015.1078952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
60 Olaya-Abril A, Jiménez-Munguía I, Gómez-Gascón L, Obando I, Rodríguez-Ortega MJ. A Pneumococcal Protein Array as a Platform to Discover Serodiagnostic Antigens Against Infection. Mol Cell Proteomics 2015;14:2591-608. [PMID: 26183717 DOI: 10.1074/mcp.M115.049544] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
61 Lagousi T, Basdeki P, Routsias J, Spoulou V. Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens. Vaccines (Basel) 2019;7:E9. [PMID: 30669439 DOI: 10.3390/vaccines7010009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
62 Odusanya OO, Kuyinu YA, Kehinde OA, Shafi F, François N, Yarzabal JP, Dobbelaere K, Rüggeberg JU, Borys D, Schuerman L. Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life. Hum Vaccin Immunother 2014;10:757-66. [PMID: 24356787 DOI: 10.4161/hv.27276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
63 Chan J, Nguyen CD, Dunne EM, Kim Mulholland E, Mungun T, Pomat WS, Rafai E, Satzke C, Weinberger DM, Russell FM. Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries. Vaccine 2019;37:6299-309. [PMID: 31500968 DOI: 10.1016/j.vaccine.2019.08.073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
64 Emmadi M, Khan N, Lykke L, Reppe K, G Parameswarappa S, Lisboa MP, Wienhold SM, Witzenrath M, Pereira CL, Seeberger PH. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. J Am Chem Soc 2017;139:14783-91. [PMID: 28945368 DOI: 10.1021/jacs.7b07836] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
65 Fu J, Yi R, Jiang Y, Xu S, Qin P, Liang Z, Chen J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: a meta-analysis. BMC Pediatr 2019;19:424. [PMID: 31711442 DOI: 10.1186/s12887-019-1722-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
66 Porat N, Benisty R, Givon-lavi N, Trefler R, Dagan R. The impact of pneumococcal conjugate vaccines on carriage of and disease caused by Streptococcus pneumoniae serotypes 6C and 6D in southern Israel. Vaccine 2016;34:2806-12. [DOI: 10.1016/j.vaccine.2016.04.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
67 Niedzielski A, Korona-Glowniak I, Malm A. High prevalence of Streptococcus pneumoniae in adenoids and nasopharynx in preschool children with recurrent upper respiratory tract infections in Poland--distribution of serotypes and drug resistance patterns. Med Sci Monit 2013;19:54-60. [PMID: 23328644 DOI: 10.12659/msm.883742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
68 Wiysonge CS, Armah GE, Madhi SA, Were F, Kitaka SB, Akoua-Koffi C, Gresenguet G, Gatheru Z, Maranga PW, Dicko A, Falade AG, Boula AY, Kuit SB, Odusanya OO, Sow PS, Lakhani N, Mpabalwani EM, Tamfum JJ, Hussey GD. The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative. Pan Afr Med J 2011;8:24. [PMID: 22121433 DOI: 10.4314/pamj.v8i1.71081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
69 Keenan JD, Sahlu I, McGee L, Cevallos V, Vidal JE, Chochua S, Hawkins P, Gebre T, Tadesse Z, Emerson PM, Gaynor BD, Lietman TM, Klugman KP. Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma. J Pediatric Infect Dis Soc 2016;5:222-6. [PMID: 27199475 DOI: 10.1093/jpids/piu143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
70 Wong SS, Quan Toh Z, Dunne EM, Mulholland EK, Tang ML, Robins-Browne RM, Licciardi PV, Satzke C. Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG. BMC Res Notes 2013;6:135. [PMID: 23561014 DOI: 10.1186/1756-0500-6-135] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
71 Zhao W, Pan F, Wang B, Wang C, Sun Y, Zhang T, Shi Y, Zhang H. Epidemiology Characteristics of Streptococcus pneumoniae From Children With Pneumonia in Shanghai: A Retrospective Study. Front Cell Infect Microbiol 2019;9:258. [PMID: 31380301 DOI: 10.3389/fcimb.2019.00258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
72 Malchrzak W, Mastalerz-Migas A. Epidemiologic Benefits of Pneumococcal Vaccine Introduction into Preventive Vaccination Programs. Adv Exp Med Biol 2021;1324:11-9. [PMID: 33136238 DOI: 10.1007/5584_2020_589] [Reference Citation Analysis]
73 Chaguza C, Cornick JE, Everett DB. Mechanisms and impact of genetic recombination in the evolution of Streptococcus pneumoniae. Comput Struct Biotechnol J 2015;13:241-7. [PMID: 25904996 DOI: 10.1016/j.csbj.2015.03.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
74 Izurieta P, Bahety P, Adegbola R, Clarke C, Hoet B. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Review of Vaccines 2018;17:479-93. [DOI: 10.1080/14760584.2018.1413354] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
75 Licciardi PV, Balloch A, Russell FM, Burton RL, Lin J, Nahm MH, Mulholland EK, Tang ML. Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses. J Allergy Clin Immunol 2012;129:794-800.e2. [PMID: 22305678 DOI: 10.1016/j.jaci.2011.11.043] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
76 Arguedas A, Soley C, Abdelnour A. Prevenar experience. Vaccine 2011;29:C26-34. [DOI: 10.1016/j.vaccine.2011.06.104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
77 Anish C, Schumann B, Pereira CL, Seeberger PH. Chemical biology approaches to designing defined carbohydrate vaccines. Chem Biol 2014;21:38-50. [PMID: 24439205 DOI: 10.1016/j.chembiol.2014.01.002] [Cited by in Crossref: 108] [Cited by in F6Publishing: 97] [Article Influence: 18.0] [Reference Citation Analysis]
78 Kalina WV, Souza V, Wu K, Giardina P, McKeen A, Jiang Q, Tan C, French R, Ren Y, Belanger K, McElhiney S, Unnithan M, Cheng H, Mininni T, Giordano-Schmidt D, Gessner BD, Jansen KU, Pride MW. Qualification and Clinical Validation of an Immunodiagnostic Assay for Detecting 11 Additional Streptococcus pneumoniae Serotype-specific Polysaccharides in Human Urine. Clin Infect Dis 2020;71:e430-8. [PMID: 32072165 DOI: 10.1093/cid/ciaa158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
79 Balsells E, Dagan R, Yildirim I, Gounder PP, Steens A, Muñoz-Almagro C, Mameli C, Kandasamy R, Givon Lavi N, Daprai L, van der Ende A, Trzciński K, Nzenze SA, Meiring S, Foster D, Bulkow LR, Rudolph K, Valero-Rello A, Ducker S, Vestrheim DF, von Gottberg A, Pelton SI, Zuccotti G, Pollard AJ, Sanders EAM, Campbell H, Madhi SA, Nair H, Kyaw MH. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect 2018;77:368-78. [PMID: 29964140 DOI: 10.1016/j.jinf.2018.06.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
80 Scott P, Rutjes AW, Bermetz L, Robert N, Scott S, Lourenço T, Egger M, Low N. Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis. Vaccine 2011;29:9711-21. [DOI: 10.1016/j.vaccine.2011.07.042] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
81 Liu Y, Xu Y, Wang J, Che X, Gu W, Du J, Zhang X, Zhang X, Jiang W, Chen J, An Z. Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups. Hum Vaccin Immunother 2021;17:157-61. [PMID: 32530728 DOI: 10.1080/21645515.2020.1765620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
82 Lu YJ, Zhang F, Sayeed S, Thompson CM, Szu S, Anderson PW, Malley R. A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi. Vaccine 2012;30:3405-12. [PMID: 22465750 DOI: 10.1016/j.vaccine.2012.03.039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
83 Zhou H, Guo J, Qin T, Ren H, Xu Y, Wang C, Xu X. Serotype and MLST-based inference of population structure of clinical Streptococcus pneumoniae from invasive and noninvasive pneumococcal disease. Infect Genet Evol 2017;55:104-11. [PMID: 28867594 DOI: 10.1016/j.meegid.2017.08.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
84 Awasthi S, Rastogi T, Mishra N, Chauhan A, Mohindra N, Shukla RC, Agarwal M, Pandey CM, Kohli N, Study Group C. Chest radiograph findings in children aged 2-59 months hospitalised with community-acquired pneumonia, prior to the introduction of pneumococcal conjugate vaccine in India: a prospective multisite observational study. BMJ Open 2020;10:e034066. [PMID: 32385059 DOI: 10.1136/bmjopen-2019-034066] [Reference Citation Analysis]
85 McIntosh ED, Reinert RR. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev Vaccines 2011;10:109-29. [PMID: 21162625 DOI: 10.1586/erv.10.145] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
86 Men W, Dong Q, Shi W, Yao K. Serotype distribution and antimicrobial resistance patterns of invasive pneumococcal disease isolates from children in mainland China-a systematic review. Braz J Microbiol 2020;51:665-72. [PMID: 31797324 DOI: 10.1007/s42770-019-00198-9] [Reference Citation Analysis]
87 Usuf E, Bottomley C, Adegbola RA, Hall A. Pneumococcal carriage in sub-Saharan Africa--a systematic review. PLoS One 2014;9:e85001. [PMID: 24465464 DOI: 10.1371/journal.pone.0085001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
88 Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, Tregnaghi M, Sierra A, Rodriguez M, Troitiño M, Carabajal C, Falaschi A, Leandro A, Castrejón MM, Lepetic A, Lommel P, Hausdorff WP, Borys D, Ruiz Guiñazú J, Ortega-Barría E, Yarzábal JP, Schuerman L; COMPAS Group. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. PLoS Med 2014;11:e1001657. [PMID: 24892763 DOI: 10.1371/journal.pmed.1001657] [Cited by in Crossref: 164] [Cited by in F6Publishing: 147] [Article Influence: 23.4] [Reference Citation Analysis]
89 Dicko A, Odusanya OO, Diallo AI, Santara G, Barry A, Dolo A, Diallo A, Kuyinu YA, Kehinde OA, François N, Borys D, Yarzabal JP, Moreira M, Schuerman L. Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial. BMC Public Health 2011;11:882. [PMID: 22112189 DOI: 10.1186/1471-2458-11-882] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
90 Devine VT, Jefferies JM, Clarke SC, Faust SN. Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci. J Immunol Res 2015;2015:394368. [PMID: 26351646 DOI: 10.1155/2015/394368] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
91 Myint TT, Madhava H, Balmer P, Christopoulou D, Attal S, Menegas D, Sprenger R, Bonnet E. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review. Adv Ther 2013;30:127-51. [PMID: 23397399 DOI: 10.1007/s12325-013-0007-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 9.9] [Reference Citation Analysis]
92 Magomani V, Wolter N, Tempia S, du Plessis M, de Gouveia L, von Gottberg A. Challenges of using molecular serotyping for surveillance of pneumococcal disease. J Clin Microbiol 2014;52:3271-6. [PMID: 24958802 DOI: 10.1128/JCM.01061-14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
93 Brouwer MC, van de Beek D. Epidemiology of community-acquired bacterial meningitis. Curr Opin Infect Dis 2018;31:78-84. [PMID: 29176349 DOI: 10.1097/QCO.0000000000000417] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
94 Rozenbaum MH, Boersma C, Postma MJ, Hak E. Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination. Expert Review of Vaccines 2014;10:187-99. [DOI: 10.1586/erv.10.163] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
95 Seki M, Kilgore PE, Kim EJ, Ohnishi M, Hayakawa S, Kim DW. Loop-Mediated Isothermal Amplification Methods for Diagnosis of Bacterial Meningitis. Front Pediatr 2018;6:57. [PMID: 29594087 DOI: 10.3389/fped.2018.00057] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
96 Singh J, Sundaresan S, Manoharan A, Shet A. Serotype distribution and antimicrobial susceptibility pattern in children ≤ 5 years with invasive pneumococcal disease in India – A systematic review. Vaccine 2017;35:4501-9. [DOI: 10.1016/j.vaccine.2017.06.079] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
97 Chan J, Nguyen CD, Lai JYR, Dunne EM, Andrews R, Blyth CC, Datta S, Fox K, Ford R, Hinds J, La Vincente S, Lehmann D, Lim R, Mungun T, Newton PN, Phetsouvanh R, Pomat WS, Xeuatvongsa A, von Mollendorf C, Dance DAB, Satzke C, Muholland K, Russell FM; PneuCAPTIVE Protocol Group. Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study. BMJ Open 2018;8:e021512. [PMID: 29776921 DOI: 10.1136/bmjopen-2018-021512] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
98 Nzoyikorera N, Diawara I, Fresia P, Maaloum F, Katfy K, Nayme K, Maaloum M, Cornick J, Chaguza C, Timinouni M, Belabess H, Zerouali K, Elmdaghri N. Whole genomic comparative analysis of Streptococcus pneumoniae serotype 1 isolates causing invasive and non-invasive infections among children under 5 years in Casablanca, Morocco. BMC Genomics 2021;22:39. [PMID: 33413118 DOI: 10.1186/s12864-020-07316-0] [Reference Citation Analysis]
99 Kuttel M, Gordon M, Ravenscroft N. Comparative simulation of pneumococcal serogroup 19 polysaccharide repeating units with two carbohydrate force fields. Carbohydr Res 2014;390:20-7. [PMID: 24681444 DOI: 10.1016/j.carres.2014.02.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
100 Dananché C, Paranhos-Baccalà G, Messaoudi M, Sylla M, Awasthi S, Bavdekar A, Sanghavi S, Diallo S, Pape JW, Rouzier V, Chou M, Eap T, Rakoto-Andrianarivelo M, Maeder M, Wang J, Ren L, Dash-Yandag B, Nymadawa P, Guillen R, Russomando G, Endtz H, Komurian-Pradel F, Vanhems P, Sánchez Picot V. Serotypes of Streptococcus pneumoniae in Children Aged <5 Years Hospitalized With or Without Pneumonia in Developing and Emerging Countries: A Descriptive, Multicenter Study. Clin Infect Dis 2020;70:875-83. [PMID: 31556939 DOI: 10.1093/cid/ciz277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
101 Kuttel MM, Ravenscroft N. Conformation and Cross-Protection in Group B Streptococcus Serotype III and Streptococcus pneumoniae Serotype 14: A Molecular Modeling Study. Pharmaceuticals (Basel) 2019;12:E28. [PMID: 30781826 DOI: 10.3390/ph12010028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
102 Nurse-Lucas M, McGee L, Hawkins PA, Swanston WH, Akpaka PE. Serotypes and genotypes of Streptococcus pneumoniae isolates from Trinidad and Tobago. Int J Infect Dis 2016;46:100-6. [PMID: 27062986 DOI: 10.1016/j.ijid.2016.04.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
103 Grousd JA, Rich HE, Alcorn JF. Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia. Clin Microbiol Rev 2019;32:e00107-18. [PMID: 31142498 DOI: 10.1128/CMR.00107-18] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
104 Pereira CL, Geissner A, Anish C, Seeberger PH. Synthetische Oligosaccharide belegen die immunologische Bedeutung der Pyruvatmodifikation im Kapselpolysaccharid von Serotyp 4 Streptococcus pneumoniae. Angew Chem 2015;127:10154-7. [DOI: 10.1002/ange.201504847] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
105 Muñoz-Almagro C, Navarro-Torne A, Pallares R. Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines. Curr Infect Dis Rep 2013;15:184-90. [PMID: 23381547 DOI: 10.1007/s11908-013-0326-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
106 Chen K, Zhang X, Shan W, Zhao G, Zhang T. Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis. Hum Vaccin Immunother 2018;14:1453-63. [PMID: 29451838 DOI: 10.1080/21645515.2018.1435224] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
107 Davis S, Feikin D, Johnson HL. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review. BMC Public Health 2013;13 Suppl 3:S21. [PMID: 24564188 DOI: 10.1186/1471-2458-13-S3-S21] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
108 Olaya-Abril A, Jiménez-Munguía I, Gómez-Gascón L, Obando I, Rodríguez-Ortega MJ. Identification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults. PLoS One 2013;8:e70365. [PMID: 23894641 DOI: 10.1371/journal.pone.0070365] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
109 Ceyhan M, Gurler N, Yaman A, Ozturk C, Oksuz L, Ozkan S, Keser M, Salman N, Alhan E, Esel D, Gultekin M, Camcioglu Y, Gul M, Sorguc Y, Aydemir S, Gunaydin M, Yakupogullari Y, Kizirgil A. Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide. Clin Vaccine Immunol 2011;18:1028-30. [PMID: 21508171 DOI: 10.1128/CVI.00526-10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
110 Deloria Knoll M, Bennett JC, Garcia Quesada M, Kagucia EW, Peterson ME, Feikin DR, Cohen AL, Hetrich MK, Yang Y, Sinkevitch JN, Ampofo K, Aukes L, Bacci S, Bigogo G, Brandileone MC, Bruce MG, Camilli R, Castilla J, Chan G, Chanto Chacón G, Ciruela P, Cook H, Corcoran M, Dagan R, Danis K, de Miguel S, De Wals P, Desmet S, Galloway Y, Georgakopoulou T, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, Lara CS, León ME, Lepp T, Mackenzie GA, Mad'arová L, McGeer A, Mungun T, Mwenda JM, Nuorti JP, Nzoyikorera N, Oishi K, De Oliveira LH, Paragi M, Pilishvili T, Puentes R, Rafai E, Saha SK, Savrasova L, Savulescu C, Scott JA, Scott KJ, Serhan F, Setchanova LP, Sinkovec Zorko N, Skoczyńska A, Swarthout TD, Valentiner-Branth P, van der Linden M, Vestrheim DF, von Gottberg A, Yildirim I, Hayford K, The Pserenade Team. Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project. Microorganisms 2021;9:742. [PMID: 33918127 DOI: 10.3390/microorganisms9040742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
111 Walekhwa M, Muturi M, Gunturu R, Kenya E, Kabera B. Streptococcus pneumoniae Serotype Epidemiology among PCV-10 Vaccinated and Unvaccinated Children at Gertrude's Children's Hospital, Nairobi County: A Cross-Sectional Study. F1000Res 2018;7:879. [PMID: 30800286 DOI: 10.12688/f1000research.14387.2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Verghese VP, Veeraraghavan B, Jayaraman R, Varghese R, Neeravi A, Jayaraman Y, Thomas K, Mehendale SM. Increasing incidence of penicillin- and cefotaxime-resistant Streptococcus pneumoniae causing meningitis in India: Time for revision of treatment guidelines? Indian J Med Microbiol 2017;35:228-36. [PMID: 28681811 DOI: 10.4103/ijmm.IJMM_17_124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
113 Gervaix A, Taguebue J, Bescher BN, Corbeil J, Raymond F, Alcoba G, Kobela M, Tetanye E. Bacterial meningitis and pneumococcal serotype distribution in children in cameroon. Pediatr Infect Dis J 2012;31:1084-7. [PMID: 22653488 DOI: 10.1097/INF.0b013e318260552d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
114 Yu YY, Xie XH, Ren L, Deng Y, Gao Y, Zhang Y, Li H, Luo J, Luo ZX, Liu EM. Epidemiological characteristics of nasopharyngeal Streptococcus pneumoniae strains among children with pneumonia in Chongqing, China. Sci Rep 2019;9:3324. [PMID: 30824811 DOI: 10.1038/s41598-019-40088-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
115 Hammitt LL, Etyang AO, Morpeth SC, Ojal J, Mutuku A, Mturi N, Moisi JC, Adetifa IM, Karani A, Akech DO, Otiende M, Bwanaali T, Wafula J, Mataza C, Mumbo E, Tabu C, Knoll MD, Bauni E, Marsh K, Williams TN, Kamau T, Sharif SK, Levine OS, Scott JAG. Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study. Lancet 2019;393:2146-54. [PMID: 31000194 DOI: 10.1016/S0140-6736(18)33005-8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 28] [Article Influence: 28.0] [Reference Citation Analysis]
116 Giglio N, Micone P, Gentile A. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America. Vaccine 2011;29 Suppl 3:C35-42. [PMID: 21896351 DOI: 10.1016/j.vaccine.2011.06.095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
117 Whitney CG. More evidence for use of pneumococcal conjugate vaccines. The Lancet 2013;381:182-3. [DOI: 10.1016/s0140-6736(12)61957-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
118 Tricarico S, McNeil HC, Cleary DW, Head MG, Lim V, Yap IKS, Wie CC, Tan CS, Norazmi MN, Aziah I, Cheah ESG, Faust SN, Jefferies JMC, Roderick PJ, Moore M, Yuen HM, Newell ML, McGrath N, Doncaster CP, Kraaijeveld AR, Webb JS, Clarke SC. Pneumococcal conjugate vaccine implementation in middle-income countries. Pneumonia (Nathan) 2017;9:6. [PMID: 28702308 DOI: 10.1186/s41479-017-0030-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
119 Mitchell R, Trück J, Pollard AJ. Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years. Expert Opin Biol Ther 2013;13:1451-65. [PMID: 23889554 DOI: 10.1517/14712598.2013.824419] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
120 Clarke E, Bashorun A, Adigweme I, Badjie Hydara M, Umesi A, Futa A, Ochoge M, Obayemi D, Edem B, Saidy-Jah E, Onwuchekwa C, Dhere R, Sethna V, Kampmann B, Goldblatt D, Taylor D, Andi-Lolo I, Hosken N, Antony K, Innis BL, Alderson MR, Lamola S. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Infect Dis 2021;21:834-46. [PMID: 33516293 DOI: 10.1016/S1473-3099(20)30735-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
121 Roca A, Bojang A, Bottomley C, Gladstone RA, Adetifa JU, Egere U, Burr S, Antonio M, Bentley S, Kampmann B; Pneumo13 Study Group. Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia. Vaccine 2015;33:7144-51. [PMID: 26592141 DOI: 10.1016/j.vaccine.2015.11.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
122 Adetifa IM, Antonio M, Okoromah CA, Ebruke C, Inem V, Nsekpong D, Bojang A, Adegbola RA. Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology. PLoS One 2012;7:e30548. [PMID: 22291984 DOI: 10.1371/journal.pone.0030548] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
123 Cornick JE, Everett DB, Broughton C, Denis BB, Banda DL, Carrol ED, Parry CM. Invasive Streptococcus pneumoniae in children, Malawi, 2004-2006. Emerg Infect Dis 2011;17:1107-9. [PMID: 21749782 DOI: 10.3201/eid/1706.101404] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
124 Gladstone RA, Jefferies JM, Faust SN, Clarke SC. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults. Expert Rev Vaccines 2012;11:889-902. [PMID: 23002969 DOI: 10.1586/erv.12.68] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
125 Binks MJ, Beissbarth J, Oguoma VM, Pizzutto SJ, Leach AJ, Smith-Vaughan HC, McHugh L, Andrews RM, Webby R, Morris PS, Chang AB. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study. Lancet Child Adolesc Health 2020;4:425-34. [PMID: 32450122 DOI: 10.1016/S2352-4642(20)30090-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
126 Caggiano S, Ullmann N, De Vitis E, Trivelli M, Mariani C, Podagrosi M, Ursitti F, Bertolaso C, Putotto C, Unolt M, Pietravalle A, Pansa P, Mphayokulela K, Lemmo MI, Mkwambe M, Kazaura J, Duse M, Nieddu F, Azzari C, Cutrera R. Factors That Negatively Affect the Prognosis of Pediatric Community-Acquired Pneumonia in District Hospital in Tanzania. Int J Mol Sci 2017;18:E623. [PMID: 28335406 DOI: 10.3390/ijms18030623] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
127 Iroh Tam PY, Thielen BK, Obaro SK, Brearley AM, Kaizer AM, Chu H, Janoff EN. Childhood pneumococcal disease in Africa - A systematic review and meta-analysis of incidence, serotype distribution, and antimicrobial susceptibility. Vaccine 2017;35:1817-27. [PMID: 28284682 DOI: 10.1016/j.vaccine.2017.02.045] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
128 Selva L, del Amo E, Brotons P, Muñoz-Almagro C. Rapid and easy identification of capsular serotypes of Streptococcus pneumoniae by use of fragment analysis by automated fluorescence-based capillary electrophoresis. J Clin Microbiol 2012;50:3451-7. [PMID: 22875895 DOI: 10.1128/JCM.01368-12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
129 Hawkins P, Mercado E, Chochua S, Castillo ME, Reyes I, Chaparro E, Gladstone R, Bentley SD, Breiman RF, Metcalf BJ, Beall B, Ochoa TJ, McGee L. Key features of invasive pneumococcal isolates recovered in Lima, Peru determined through whole genome sequencing. Int J Med Microbiol 2017;307:415-21. [PMID: 28756964 DOI: 10.1016/j.ijmm.2017.07.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
130 Ziane H, Manageiro V, Ferreira E, Moura IB, Bektache S, Tazir M, Caniça M. Serotypes and Antibiotic Susceptibility of Streptococcus pneumoniae Isolates from Invasive Pneumococcal Disease and Asymptomatic Carriage in a Pre-vaccination Period, in Algeria. Front Microbiol 2016;7:803. [PMID: 27379023 DOI: 10.3389/fmicb.2016.00803] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
131 Jaiswal N, Singh M, Thumburu KK, Bharti B, Agarwal A, Kumar A, Kaur H, Chadha N. Burden of invasive pneumococcal disease in children aged 1 month to 12 years living in South Asia: a systematic review. PLoS One 2014;9:e96282. [PMID: 24798424 DOI: 10.1371/journal.pone.0096282] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
132 Chen C, Cervero Liceras F, Flasche S, Sidharta S, Yoong J, Sundaram N, Jit M. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis. Lancet Glob Health 2019;7:e58-67. [PMID: 30554762 DOI: 10.1016/S2214-109X(18)30422-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
133 Fernández Chávez AC, García Comas L, Gómez Barroso D, Ramis Prieto R, López Fresneña N, Bishofberguer Valdes C, Aranaz Andrés JM. Spatial and temporal analysis of invasive pneumococcal disease due to erythromycinresistant serotypes. Enferm Infecc Microbiol Clin 2021:S0213-005X(21)00205-6. [PMID: 34256972 DOI: 10.1016/j.eimc.2021.06.009] [Reference Citation Analysis]
134 Warren JL, Shioda K, Kürüm E, Schuck-Paim C, Lustig R, Taylor RJ, Simonsen L, Weinberger DM. Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil. Clin Infect Dis 2017;65:1813-8. [PMID: 29020195 DOI: 10.1093/cid/cix638] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
135 Memish ZA, Al-Tawfiq JA, Almasri M, Akkad N, Yezli S, Turkestani A, van der Linden M, Assiri A. A cohort study of the impact and acquisition of naspharyngeal carriage of Streptococcus pneumoniae during the Hajj. Travel Med Infect Dis. 2016;14:242-247. [PMID: 27189624 DOI: 10.1016/j.tmaid.2016.05.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
136 Nunes MC, Madhi SA. Review on the immunogenicity and safety of PCV-13 in infants and toddlers. Expert Review of Vaccines 2014;10:951-80. [DOI: 10.1586/erv.11.76] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
137 Lundgren A, Bhuiyan TR, Novak D, Kaim J, Reske A, Lu YJ, Qadri F, Malley R. Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine 2012;30:3897-907. [PMID: 22504663 DOI: 10.1016/j.vaccine.2012.03.082] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
138 Su H, Liu Q, Bian X, Wang S, Curtiss R 3rd, Kong Q. Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines. Proc Natl Acad Sci U S A 2021;118:e2013350118. [PMID: 33380455 DOI: 10.1073/pnas.2013350118] [Reference Citation Analysis]
139 Behera A, Kulkarni SS. Chemical Synthesis of Rare, Deoxy-Amino Sugars Containing Bacterial Glycoconjugates as Potential Vaccine Candidates. Molecules 2018;23:E1997. [PMID: 30103434 DOI: 10.3390/molecules23081997] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
140 Ochs MM, Williams K, Sheung A, Lheritier P, Visan L, Rouleau N, Proust E, de Montfort A, Tang M, Mari K, Hopfer R, Gallichan S, Brookes RH. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge. Hum Vaccin Immunother 2016;12:2946-52. [PMID: 27392182 DOI: 10.1080/21645515.2016.1202389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
141 Seco BMS, Xu FF, Grafmüller A, Kottari N, Pereira CL, Seeberger PH. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against Streptococcus pneumoniae Serotype 14. ACS Chem Biol 2020;15:2395-405. [PMID: 32835479 DOI: 10.1021/acschembio.0c00360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
142 Carter MJ, Gurung P, Jones C, Rajkarnikar S, Kandasamy R, Gurung M, Thorson S, Gautam MC, Prajapati KG, Khadka B, Maharjan A, Knight JC, Murdoch DR, Darton TC, Voysey M, Wahl B, O'Brien KL, Kelly S, Ansari I, Shah G, Ekström N, Melin M, Pollard AJ, Kelly DF, Shrestha S. Assessment of an Antibody-in-Lymphocyte Supernatant Assay for the Etiological Diagnosis of Pneumococcal Pneumonia in Children. Front Cell Infect Microbiol 2019;9:459. [PMID: 32039044 DOI: 10.3389/fcimb.2019.00459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 DeAntonio R, Yarzabal JP, Cruz JP, Schmidt JE, Kleijnen J. Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review. Hum Vaccin Immunother 2016;12:2422-40. [PMID: 27269963 DOI: 10.1080/21645515.2016.1174356] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
144 Inghammar M, By Y, Farris C, Phe T, Borand L, Kerleguer A, Goyet S, Saphonn V, Phoeung C, Vong S, Rammaert B, Mayaud C, Guillard B, Yasuda C, Kasper MR, Ford G, Newell SW, An US, Sokhal B, Touch S, Turner P, Jacobs J, Messaoudi M, Komurian-Pradel F, Tarantola A. Serotype Distribution of Clinical Streptococcus pneumoniae Isolates before the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Cambodia. Am J Trop Med Hyg 2018;98:791-6. [PMID: 29313476 DOI: 10.4269/ajtmh.17-0692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
145 Wagenvoort GH, Sanders EA, Vlaminckx BJ, Elberse KE, de Melker HE, van der Ende A, Knol MJ. Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands. Vaccine 2016;34:1077-85. [PMID: 26778420 DOI: 10.1016/j.vaccine.2015.12.066] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
146 Brookes RH, Ming M, Williams K, Hopfer R, Gurunathan S, Gallichan S, Tang M, Ochs MM. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies. Hum Vaccin Immunother 2015;11:1836-9. [PMID: 25912273 DOI: 10.1080/21645515.2015.1039210] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
147 Ortika BD, Habib M, Dunne EM, Porter BD, Satzke C. Production of latex agglutination reagents for pneumococcal serotyping. BMC Res Notes 2013;6:49. [PMID: 23379961 DOI: 10.1186/1756-0500-6-49] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
148 Cockeran R, Herbert JA, Mitchell TJ, Dix-Peek T, Dickens C, Anderson R, Feldman C. Exposure of a 23F serotype strain of Streptococcus pneumoniae to cigarette smoke condensate is associated with selective upregulation of genes encoding the two-component regulatory system 11 (TCS11). Biomed Res Int 2014;2014:976347. [PMID: 25013815 DOI: 10.1155/2014/976347] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
149 Lyu S, Hu HL, Yang YH, Yao KH. A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed. Expert Rev Vaccines 2017;16:997-1006. [PMID: 28745918 DOI: 10.1080/14760584.2017.1360771] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
150 Kamng'ona AW, Hinds J, Bar-Zeev N, Gould KA, Chaguza C, Msefula C, Cornick JE, Kulohoma BW, Gray K, Bentley SD, French N, Heyderman RS, Everett DB. High multiple carriage and emergence of Streptococcus pneumoniae vaccine serotype variants in Malawian children. BMC Infect Dis 2015;15:234. [PMID: 26088623 DOI: 10.1186/s12879-015-0980-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
151 Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY. Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants. PLoS One 2015;10:e0144739. [PMID: 26658902 DOI: 10.1371/journal.pone.0144739] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
152 Shakoor S, Kabir F, Khowaja AR, Qureshi SM, Jehan F, Qamar F, Whitney CG, Zaidi AK. Pneumococcal serotypes and serogroups causing invasive disease in Pakistan, 2005-2013. PLoS One 2014;9:e98796. [PMID: 24892937 DOI: 10.1371/journal.pone.0098796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
153 Zhang X, Tian J, Shan W, Xue J, Tao Y, Geng Q, Ding Y, Zhao G, Zhang T. Characteristics of pediatric invasive pneumococcal diseases and the pneumococcal isolates in Suzhou, China before introduction of PCV13. Vaccine 2017;35:4119-25. [DOI: 10.1016/j.vaccine.2017.06.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
154 Ginders M, Leschnik M, Künzel F, Kampner D, Mikula C, Steindl G, Eichhorn I, Feßler AT, Schwarz S, Spergser J, Loncaric I. Characterization of Streptococcus pneumoniae isolates from Austrian companion animals and horses. Acta Vet Scand 2017;59:79. [PMID: 29137652 DOI: 10.1186/s13028-017-0348-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
155 Løchen A, Croucher NJ, Anderson RM. Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency. Sci Rep 2020;10:18977. [PMID: 33149149 DOI: 10.1038/s41598-020-75691-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
156 Clarke TN, Schilling MA, Melendez LA, Isidean SD, Porter CK, Poly FM. A systematic review and meta-analysis of Penner serotype prevalence of Campylobacter jejuni in low- and middle-income countries. PLoS One 2021;16:e0251039. [PMID: 33951106 DOI: 10.1371/journal.pone.0251039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Bennett JC, Hetrich MK, Garcia Quesada M, Sinkevitch JN, Deloria Knoll M, Feikin DR, Zeger SL, Kagucia EW, Cohen AL, Ampofo K, Brandileone MC, Bruden D, Camilli R, Castilla J, Chan G, Cook H, Cornick JE, Dagan R, Dalby T, Danis K, de Miguel S, De Wals P, Desmet S, Georgakopoulou T, Gilkison C, Grgic-Vitek M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, MacDonald L, Mackenzie GA, Mad'arová L, McGeer A, Mereckiene J, Morfeldt E, Mungun T, Muñoz-Almagro C, Nuorti JP, Paragi M, Pilishvili T, Puentes R, Saha SK, Sahu Khan A, Savrasova L, Scott JA, Skoczyńska A, Suga S, van der Linden M, Verani JR, von Gottberg A, Winje BA, Yildirim I, Zerouali K, Hayford K, The Pserenade Team. Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project. Microorganisms 2021;9:696. [PMID: 33801760 DOI: 10.3390/microorganisms9040696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
158 Licciardi PV, Russell FM, Balloch A, Burton RL, Nahm MH, Gilbert G, Tang ML, Mulholland EK. Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage. Vaccine 2014;32:2321-7. [PMID: 24613524 DOI: 10.1016/j.vaccine.2014.02.064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
159 John M, Dunne EM, Licciardi PV, Satzke C, Wijburg O, Robins-Browne RM, O'Leary S. Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease? Eur J Clin Microbiol Infect Dis 2013;32:1101-10. [PMID: 23512465 DOI: 10.1007/s10096-013-1858-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
160 Ahmed SS, Lessa FC, Coradin H, Sánchez J, Carvalho MDG, Soda E, Peña C, Fernández J, Cedano D, Whitney CG, Feris-Iglesias J. High Prevalence of Vaccine-Type Infections Among Children with Pneumococcal Pneumonia and Effusion After 13-Valent Pneumococcal Conjugate Vaccine Introduction in the Dominican Republic. J Infect Dis 2021;224:S228-36. [PMID: 34469563 DOI: 10.1093/infdis/jiab134] [Reference Citation Analysis]
161 Jaiswal N, Singh M, Das RR, Jindal I, Agarwal A, Thumburu KK, Kumar A, Chauhan A. Distribution of serotypes, vaccine coverage, and antimicrobial susceptibility pattern of Streptococcus pneumoniae in children living in SAARC countries: a systematic review. PLoS One 2014;9:e108617. [PMID: 25268974 DOI: 10.1371/journal.pone.0108617] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
162 Sibak M, Moussa I, El-tantawy N, Badr S, Chaudhri I, Allam E, Baxter L, Abo Freikha S, Hoestlandt C, Lara C, Hajjeh R, Munier A. Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013. Vaccine 2015;33:A182-91. [DOI: 10.1016/j.vaccine.2014.12.044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
163 Principi N, Esposito S. Development of pneumococcal vaccines over the last 10 years. Expert Opinion on Biological Therapy 2017;18:7-17. [DOI: 10.1080/14712598.2018.1384462] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
164 Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL; Pneumococcal Carriage Group. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 2012;11:841-55. [PMID: 22913260 DOI: 10.1586/erv.12.53] [Cited by in Crossref: 404] [Cited by in F6Publishing: 365] [Article Influence: 44.9] [Reference Citation Analysis]
165 Klugman KP, Dagan R, Malley R, Whitney CG. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 773-815.e18. [DOI: 10.1016/b978-0-323-35761-6.00045-6] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
166 Klugman KP. Contribution of vaccines to our understanding of pneumococcal disease. Philos Trans R Soc Lond B Biol Sci 2011;366:2790-8. [PMID: 21893542 DOI: 10.1098/rstb.2011.0032] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
167 Boelsen LK, Dunne EM, Lamb KE, Bright K, Cheung YB, Tikoduadua L, Russell FM, Mulholland EK, Licciardi PV, Satzke C. Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes. Vaccine 2015;33:5708-14. [PMID: 26232540 DOI: 10.1016/j.vaccine.2015.07.059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
168 Madhi SA, Nunes MC. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience. Hum Vaccin Immunother 2016;12:314-25. [PMID: 26317537 DOI: 10.1080/21645515.2015.1084450] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
169 Leung DT, Chisti MJ, Pavia AT. Prevention and Control of Childhood Pneumonia and Diarrhea. Pediatr Clin North Am 2016;63:67-79. [PMID: 26613689 DOI: 10.1016/j.pcl.2015.08.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
170 Parra EL, Ramos V, Sanabria O, Moreno J. Serotype and genotype distribution among invasive Streptococcus pneumoniae isolates in Colombia, 2005-2010. PLoS One 2014;9:e84993. [PMID: 24416330 DOI: 10.1371/journal.pone.0084993] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
171 Alderson MR, Sethna V, Newhouse LC, Lamola S, Dhere R. Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL®). Hum Vaccin Immunother 2021;17:2670-7. [PMID: 33625961 DOI: 10.1080/21645515.2021.1874219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
172 Fronczek CF, Yoon J. Biosensors for Monitoring Airborne Pathogens. J Lab Autom 2015;20:390-410. [DOI: 10.1177/2211068215580935] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
173 Gessner BD, Sanou O, Drabo A, Tamekloe TA, Yaro S, Tall H, Moïsi JC, Mueller JE, Njanpop-lafourcade B. Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007–2009. Vaccine 2012;30:G41-5. [DOI: 10.1016/j.vaccine.2012.10.052] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
174 Webster J, Theodoratou E, Nair H, Seong AC, Zgaga L, Huda T, Johnson HL, Madhi S, Rubens C, Zhang JS, El Arifeen S, Krause R, Jacobs TA, Brooks AW, Campbell H, Rudan I. An evaluation of emerging vaccines for childhood pneumococcal pneumonia. BMC Public Health 2011;11 Suppl 3:S26. [PMID: 21501444 DOI: 10.1186/1471-2458-11-S3-S26] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
175 Rhodes J, Jorakate P, Makprasert S, Sangwichian O, Kaewpan A, Akarachotpong T, Srisaengchai P, Thamthitiwat S, Khemla S, Yuenprakhon S, Paveenkittiporn W, Kerdsin A, Whistler T, Baggett HC, Gregory CJ. Population-based bloodstream infection surveillance in rural Thailand, 2007-2014. BMC Public Health 2019;19:521. [PMID: 32326935 DOI: 10.1186/s12889-019-6775-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
176 Saxena S, Khan N, Dehinwal R, Kumar A, Sehgal D. Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo. PLoS One 2015;10:e0118154. [PMID: 25689507 DOI: 10.1371/journal.pone.0118154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
177 Corcoran M, Mereckiene J, Cotter S, Murchan S, Cunney R, Humphreys H. Invasive Streptococcus pneumoniae Infections and Vaccine Failures in Children in Ireland From the Postvaccine Era From 2007 to 2018. Pediatr Infect Dis J 2020;39:339-44. [PMID: 31815827 DOI: 10.1097/INF.0000000000002549] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
178 Figueiredo AHA, Brouwer MC, van de Beek D. Acute Community-Acquired Bacterial Meningitis. Neurologic Clinics 2018;36:809-20. [DOI: 10.1016/j.ncl.2018.06.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
179 Habibi Ghahfarokhi S, Mosadegh M, Ahmadi A, Pourmand MR, Azarsa M, Rahbar M, Nikmanesh B. Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Isolates in Tehran, Iran: A Surveillance Study. Infect Drug Resist 2020;13:333-40. [PMID: 32099424 DOI: 10.2147/IDR.S234295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
180 Alicino C, Paganino C, Orsi A, Astengo M, Trucchi C, Icardi G, Ansaldi F. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis. Vaccine 2017;35:5776-85. [DOI: 10.1016/j.vaccine.2017.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
181 Dunn MG, Lessa FC, Sánchez J, Cordero R, Feris-Iglesias J, Cedano D, Carvalho MDG, Fernández J, Feemster KA. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic. J Infect Dis 2021;224:S237-47. [PMID: 34469551 DOI: 10.1093/infdis/jiab172] [Reference Citation Analysis]
182 Verguet S, Pecenka C, Johansson KA, Memirie ST, Friberg IK, Driessen JR, Jamison DT. Health Gains and Financial Risk Protection Afforded by Treatment and Prevention of Diarrhea and Pneumonia in Ethiopia: An Extended Cost-Effectiveness Analysis. In: Black R, Laxminarayan R, Temmerman M, Walker N, editors. Disease Control Priorities, Third Edition (Volume 2): Reproductive, Maternal, Newborn, and Child Health. The World Bank; 2016. pp. 345-61. [DOI: 10.1596/978-1-4648-0348-2_ch19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
183 Flasche S, Le Polain de Waroux O, O'Brien KL, Edmunds WJ. The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease. PLoS Comput Biol 2015;11:e1004173. [PMID: 25879748 DOI: 10.1371/journal.pcbi.1004173] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
184 Farkouh RA, Klok RM, Postma MJ, Roberts CS, Strutton DR. Cost–effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions. Expert Review of Vaccines 2014;11:1235-47. [DOI: 10.1586/erv.12.99] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
185 Takano C, Kuramochi Y, Seki M, Kim DW, Omagari D, Sasano M, Chang B, Ohnishi M, Kim EJ, Fuwa K, Kilgore PE, Hoshino T, Hayakawa S. Molecular serotype-specific identification of Streptococcus pneumoniae using loop-mediated isothermal amplification. Sci Rep 2019;9:19823. [PMID: 31882619 DOI: 10.1038/s41598-019-56225-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
186 Javed, Mandal PK. Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines. Carbohydr Res 2021;502:108277. [PMID: 33743443 DOI: 10.1016/j.carres.2021.108277] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Teleb N, Pilishvili T, Van Beneden C, Ghoneim A, Amjad K, Mostafa A, Estighamati AR, Smeo MN, Barkia A, Elkhatib M, Mujaly A, Ashmony H, Jassim KA, Hajjeh RA. Bacterial meningitis surveillance in the Eastern Mediterranean region, 2005-2010: successes and challenges of a regional network. J Pediatr 2013;163:S25-31. [PMID: 23773590 DOI: 10.1016/j.jpeds.2013.03.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
188 Licciardi PV, Toh ZQ, Dunne E, Wong SS, Mulholland EK, Tang M, Robins-Browne RM, Satzke C. Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome. PLoS Pathog 2012;8:e1002652. [PMID: 22685396 DOI: 10.1371/journal.ppat.1002652] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
189 Okade H, Funatsu T, Eto M, Furuya Y, Mizunaga S, Nomura N, Mitsuyama J, Yamagishi Y, Mikamo H. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period. J Infect Chemother 2014;20:423-8. [PMID: 24802765 DOI: 10.1016/j.jiac.2014.03.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
190 Saha SK, Hossain B, Islam M, Hasanuzzaman M, Saha S, Hasan M, Darmstadt GL, Chowdury M, Arifeen SE, Baqui AH, Breiman RF, Santosham M, Luby SP, Whitney CG; Pneumococcal Study Group. Epidemiology of Invasive Pneumococcal Disease in Bangladeshi Children Before Introduction of Pneumococcal Conjugate Vaccine. Pediatr Infect Dis J 2016;35:655-61. [PMID: 26658530 DOI: 10.1097/INF.0000000000001037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
191 Madhi SA, Knoll MD. An affordable pneumococcal conjugate vaccine after 20 years. Lancet Infect Dis 2021;21:751-3. [PMID: 33516294 DOI: 10.1016/S1473-3099(21)00002-5] [Reference Citation Analysis]
192 Tanmoy AM, Saha S, Darmstadt GL, Whitney CG, Saha SK. PCR-Based Serotyping of Streptococcus pneumoniae from Culture-Negative Specimens: Novel Primers for Detection of Serotypes within Serogroup 18. J Clin Microbiol 2016;54:2178-81. [PMID: 27252464 DOI: 10.1128/JCM.00419-16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Ceyhan M, Aykac K, Gurler N, Ozsurekci Y, Öksüz L, Altay Akısoglu Ö, Öz FN, Emiroglu M, TurkDagi H, Yaman A, Söyletir G, Öztürk C, Akpolat N, Özakin C, Aydın F, Aydemir Ş, Kiremitci A, Gültekin M, Camcıoglu Y, Zer Y, Güdücüoğlu H, Gülay Z, Birinci A, Arabaci C, Karbuz A, Devrim I, Sorguc Y, Baysan BÖ, Karadag Oncel E, Yilmaz N, Altintop YA. Serotype distribution of Streptococcus pneumonia in children with invasive disease in Turkey: 2015-2018. Hum Vaccin Immunother 2020;16:2773-8. [PMID: 32530357 DOI: 10.1080/21645515.2020.1747931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
194 Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, Goldblatt D, O'Brien KL, Whitney CG. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J 2014;33 Suppl 2:S109-18. [PMID: 24336053 DOI: 10.1097/INF.0000000000000078] [Cited by in Crossref: 60] [Cited by in F6Publishing: 34] [Article Influence: 8.6] [Reference Citation Analysis]
195 Ma M, Yuan M, Li M, Li X, Huang H, Wang H, Li J, Du T, Huang R. Serotype Distribution and Characteristics of the Minimum Inhibitory Concentrations of Streptococcus pneumoniae Isolated from Pediatric Patients in Kunming, China. Curr Microbiol 2021;78:954-60. [PMID: 33599832 DOI: 10.1007/s00284-021-02365-4] [Reference Citation Analysis]
196 Roberts AP, Mullany P. Tn916-like genetic elements: a diverse group of modular mobile elements conferring antibiotic resistance. FEMS Microbiol Rev 2011;35:856-71. [PMID: 21658082 DOI: 10.1111/j.1574-6976.2011.00283.x] [Cited by in Crossref: 139] [Cited by in F6Publishing: 120] [Article Influence: 13.9] [Reference Citation Analysis]
197 Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J 2014;33 Suppl 2:S140-51. [PMID: 24336056 DOI: 10.1097/INF.0000000000000082] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
198 Herbert JA, Kay EJ, Faustini SE, Richter A, Abouelhadid S, Cuccui J, Wren B, Mitchell TJ. Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine. Vaccine 2018;36:3809-19. [PMID: 29778517 DOI: 10.1016/j.vaccine.2018.05.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
199 Rodgers GL, Klugman KP. The future of pneumococcal disease prevention. Vaccine 2011;29 Suppl 3:C43-8. [PMID: 21896352 DOI: 10.1016/j.vaccine.2011.07.047] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
200 Chinen J, Paul ME, Shearer WT. Approach to the Evaluation of the Patient With Suspected Immunodeficiency. Clinical Immunology. Elsevier; 2019. pp. 451-461.e1. [DOI: 10.1016/b978-0-7020-6896-6.00032-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
201 Hocknell RE, Cleary DW, Srifeungfung S, Clarke SC. Serotype distribution of disease-causing Streptococcus pneumoniae in Thailand: A systematic review. Vaccine 2019;37:3159-66. [DOI: 10.1016/j.vaccine.2019.04.085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Colijn C, Corander J, Croucher NJ. Designing ecologically optimized pneumococcal vaccines using population genomics. Nat Microbiol 2020;5:473-85. [PMID: 32015499 DOI: 10.1038/s41564-019-0651-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 16.0] [Reference Citation Analysis]
203 Statt S, Ruan JW, Huang CT, Wu R, Kao CY. Lipidome and transcriptome profiling of pneumolysin intoxication identifies networks involved in statin-conferred protection of airway epithelial cells. Sci Rep 2015;5:10624. [PMID: 26023727 DOI: 10.1038/srep10624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
204 Cope EK, Goldstein-Daruech N, Kofonow JM, Christensen L, McDermott B, Monroy F, Palmer JN, Chiu AG, Shirtliff ME, Cohen NA, Leid JG. Regulation of virulence gene expression resulting from Streptococcus pneumoniae and nontypeable Haemophilus influenzae interactions in chronic disease. PLoS One 2011;6:e28523. [PMID: 22162775 DOI: 10.1371/journal.pone.0028523] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
205 Lee LH, Gu XX, Nahm MH. Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention. Vaccines (Basel) 2014;2:112-28. [PMID: 26344470 DOI: 10.3390/vaccines2010112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
206 Heath CJ, Nayakwadi-Singer M, King CH, Malhotra I, Mutuku F, Mukoko D, LaBeaud AD. Nasopharyngeal Carriage of Streptococcus pneumoniae in Children in Coastal Kenya. Am J Trop Med Hyg 2018;98:1046-50. [PMID: 29488456 DOI: 10.4269/ajtmh.16-0813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
207 Whitney CG, Goldblatt D, O'Brien KL. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers. Pediatr Infect Dis J 2014;33 Suppl 2:S172-81. [PMID: 24336059 DOI: 10.1097/INF.0000000000000076] [Cited by in Crossref: 54] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
208 Gámez G, Castro A, Gómez-Mejia A, Gallego M, Bedoya A, Camargo M, Hammerschmidt S. The variome of pneumococcal virulence factors and regulators. BMC Genomics 2018;19:10. [PMID: 29298677 DOI: 10.1186/s12864-017-4376-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
209 Sigaúque B, Verani JR, Massora S, Vubil D, Quintó L, Acácio S, Mandomando I, Bassat Q, Nhampossa T, Pimenta F, Sacoor C, Carvalho MDG, Macete E, Alonso PL. Burden of invasive pneumococcal disease among children in rural Mozambique: 2001-2012. PLoS One 2018;13:e0190687. [PMID: 29304066 DOI: 10.1371/journal.pone.0190687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
210 Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R; Israeli Bacteremia and Meningitis Active Surveillance Group. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine. 2012;30:6600-6607. [PMID: 22939907 DOI: 10.1016/j.vaccine.2012.08.012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
211 Bhardwaj SK, Bhardwaj N, Kumar V, Bhatt D, Azzouz A, Bhaumik J, Kim KH, Deep A. Recent progress in nanomaterial-based sensing of airborne viral and bacterial pathogens. Environ Int 2021;146:106183. [PMID: 33113463 DOI: 10.1016/j.envint.2020.106183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
212 Dicko A, Dicko Y, Barry A, Sidibe Y, Mahamar A, Santara G, Dolo A, Diallo A, Doumbo O, Shafi F, François N, Yarzabal JP, Strezova A, Borys D, Schuerman L. Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study. Hum Vaccin Immunother 2015;11:2207-14. [PMID: 26020101 DOI: 10.1080/21645515.2015.1016679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
213 Choi YH, Jit M, Gay N, Andrews N, Waight PA, Melegaro A, George R, Miller E. 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement? PLoS One 2011;6:e26190. [PMID: 22022559 DOI: 10.1371/journal.pone.0026190] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
214 Isturiz R, Sings HL, Hilton B, Arguedas A, Reinert R, Jodar L. Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert Review of Vaccines 2017;16:1007-27. [DOI: 10.1080/14760584.2017.1362339] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 15.8] [Reference Citation Analysis]
215 Mutschler H, Meinhart A. ε/ζ systems: their role in resistance, virulence, and their potential for antibiotic development. J Mol Med (Berl) 2011;89:1183-94. [PMID: 21822621 DOI: 10.1007/s00109-011-0797-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
216 von Mollendorf C, Lim R, Choummanivong M, Sychareun V, Vilivong K, Lai JYR, Chan J, Dunne EM, Phommachanh S, Moore KA, Ortika BD, Gray A, Weaver R, Mayxay M, Phetsouvanh R, Datta SS, Fox K, Newton PN, Mulholland KE, Nguyen CD, Dance DAB, Satzke C, Russell FM. Evaluation strategies for measuring pneumococcal conjugate vaccine impact in low-resource settings. Expert Rev Vaccines 2021;:1-9. [PMID: 34378467 DOI: 10.1080/14760584.2021.1965474] [Reference Citation Analysis]
217 Yu K, Qiao Y, Gu G, Gao J, Cai S, Long Z, Guo Z. Synthesis of the biological repeating unit of Streptococcus pneumoniae serotype 23F capsular polysaccharide. Org Biomol Chem 2016;14:11462-72. [DOI: 10.1039/c6ob02363k] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
218 Chaguza C, Cornick JE, Harris SR, Andam CP, Bricio-Moreno L, Yang M, Yalcin F, Ousmane S, Govindpersad S, Senghore M, Ebruke C, Du Plessis M, Kiran AM, Pluschke G, Sigauque B, McGee L, Klugman KP, Turner P, Corander J, Parkhill J, Collard JM, Antonio M, von Gottberg A, Heyderman RS, French N, Kadioglu A, Hanage WP, Everett DB, Bentley SD; PAGe Consortium. Understanding pneumococcal serotype 1 biology through population genomic analysis. BMC Infect Dis 2016;16:649. [PMID: 27821148 DOI: 10.1186/s12879-016-1987-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
219 Staples M, Graham RMA, Jennison AV, Ariotti L, Hicks V, Cook H, Krause V, Giele C, Smith HV. Molecular characterization of an Australian serotype 1 Streptococcus pneumoniae outbreak. Epidemiol Infect 2015;143:325-33. [DOI: 10.1017/s0950268814000648] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
220 Navarro-Torné A, Dias JG, Hruba F, Lopalco PL, Pastore-Celentano L, Gauci AJ; Invasive Pneumococcal Disease Study Group. Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerg Infect Dis 2015;21:417-25. [PMID: 25693604 DOI: 10.3201/eid2103.140634] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
221 Vella M, Pace D. Glycoconjugate vaccines: an update. Expert Opin Biol Ther 2015;15:529-46. [PMID: 25496172 DOI: 10.1517/14712598.2015.993375] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
222 Li MC, Wang Y, Zhang H, Liu Y, Chen XJ, Yang HW, Ma P, Wang DC, Zhang BC, Dong AY, Wang CX, Li Y, Bai P, Tang WM, Wang J, Shao ZJ, Xu YC. Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study. Hum Vaccin Immunother 2021;17:146-56. [PMID: 32530720 DOI: 10.1080/21645515.2020.1757996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
223 Jallow S, Madhi SA. Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children. Expert Rev Vaccines 2017;16:453-65. [PMID: 28351187 DOI: 10.1080/14760584.2017.1307740] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
224 Thomas JC, Kong Y, Sabharwal V, Pelton SI, Pettigrew MM. Streptococcus pneumoniae serotype 6C: an intra- and interclonal complex comparison. J Bacteriol 2011;193:3409-10. [PMID: 21551297 DOI: 10.1128/JB.05079-11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
225 Donkor ES, Dayie NT, Badoe EV. Vaccination against pneumococcus in West Africa: perspectives and prospects. Int J Gen Med 2013;6:757-64. [PMID: 24049454 DOI: 10.2147/IJGM.S45842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
226 Maestro B, Sanz JM. Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials. Antibiotics (Basel) 2016;5:E21. [PMID: 27314398 DOI: 10.3390/antibiotics5020021] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
227 Reiner RC, Welgan CA, Casey DC, Troeger CE, Baumann MM, Nguyen QP, Swartz SJ, Blacker BF, Deshpande A, Mosser JF, Osgood-Zimmerman AE, Earl L, Marczak LB, Munro SB, Miller-Petrie MK, Rodgers Kemp G, Frostad J, Wiens KE, Lindstedt PA, Pigott DM, Dwyer-Lindgren L, Ross JM, Burstein R, Graetz N, Rao PC, Khalil IA, Davis Weaver N, Ray SE, Davis I, Farag T, Brady OJ, Kraemer MUG, Smith DL, Bhatt S, Weiss DJ, Gething PW, Kassebaum NJ, Mokdad AH, Murray CJL, Hay SI. Identifying residual hotspots and mapping lower respiratory infection morbidity and mortality in African children from 2000 to 2017. Nat Microbiol 2019;4:2310-8. [PMID: 31570869 DOI: 10.1038/s41564-019-0562-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
228 Deloria Knoll M, Park DE, Johnson TS, Chandir S, Nonyane BA, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity. Pediatr Infect Dis J 2014;33 Suppl 2:S119-29. [PMID: 24336054 DOI: 10.1097/INF.0000000000000079] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 5.1] [Reference Citation Analysis]
229 Swarthout TD, Fronterre C, Lourenço J, Obolski U, Gori A, Bar-Zeev N, Everett D, Kamng'ona AW, Mwalukomo TS, Mataya AA, Mwansambo C, Banda M, Gupta S, Diggle P, French N, Heyderman RS. High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi. Nat Commun 2020;11:2222. [PMID: 32376860 DOI: 10.1038/s41467-020-15786-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 23.0] [Reference Citation Analysis]
230 Moore CE, Giess A, Soeng S, Sar P, Kumar V, Nhoung P, Bousfield R, Turner P, Stoesser N, Day NP, Parry CM. Characterisation of Invasive Streptococcus pneumoniae Isolated from Cambodian Children between 2007 - 2012. PLoS One 2016;11:e0159358. [PMID: 27448096 DOI: 10.1371/journal.pone.0159358] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
231 Khoshdel A, Rastabi RI, Doosti A, Askari S, Hafizi M. Prevalence of Heptavalent Vaccine-related Pneumococcal Serotypes in Nasopharyngeal carrier in children under five years old in Shahrekord, Iran by Multiplex-PCR during 2010- 2011. J Clin Diagn Res 2014;8:PC01-4. [PMID: 25584276 DOI: 10.7860/JCDR/2014/8970.5104] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
232 Salter SJ, Hinds J, Gould KA, Lambertsen L, Hanage WP, Antonio M, Turner P, Hermans PWM, Bootsma HJ, O'Brien KL, Bentley SD. Variation at the capsule locus, cps, of mistyped and non-typable Streptococcus pneumoniae isolates. Microbiology (Reading) 2012;158:1560-9. [PMID: 22403189 DOI: 10.1099/mic.0.056580-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
233 Pace D. Glycoconjugate vaccines. Expert Opinion on Biological Therapy 2012;13:11-33. [DOI: 10.1517/14712598.2012.725718] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
234 Wangirapan A, Ayuthaya SIN, Katip W, Kasatpibal N, Mektrirat R, Anukool U, Oberdorfer P. Serotypes and Vaccine Coverage of Streptococcus Pneumoniae Colonization in the Nasopharynx of Thai Children in Congested Areas in Chiang Mai. Pathogens 2020;9:E988. [PMID: 33255981 DOI: 10.3390/pathogens9120988] [Reference Citation Analysis]
235 Chiappini E, Inturrisi F, Orlandini E, de Martino M, de Waure C. Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000-2016 period. BMC Infect Dis 2018;18:396. [PMID: 30103691 DOI: 10.1186/s12879-018-3316-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
236 Nackers F, Cohuet S, le Polain de Waroux O, Langendorf C, Nyehangane D, Ndazima D, Nanjebe D, Karani A, Tumwesigye E, Mwanga-Amumpaire J, Scott JAG, Grais RF. Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014. Vaccine 2017;35:5271-7. [PMID: 28784282 DOI: 10.1016/j.vaccine.2017.07.081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
237 Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet 2019;394:757-79. [PMID: 31257127 DOI: 10.1016/S0140-6736(19)30721-4] [Cited by in Crossref: 208] [Cited by in F6Publishing: 142] [Article Influence: 104.0] [Reference Citation Analysis]
238 Meek B, Ekström N, Kantsø B, Almond R, Findlow J, Gritzfeld JF, Sværke Jørgensen C, Ljungberg K, Atterfelt F, Batstra MR, Andeweg K, de Jong BAW, Prince HE, Lapé-Nixon M, Gageldonk PGM, Tcherniaeva I, Aaberge I, Herstad TK, Melin M, Rijkers GT, Berbers GA. Multilaboratory Comparison of Pneumococcal Multiplex Immunoassays Used in Immunosurveillance of Streptococcus pneumoniae across Europe. mSphere 2019;4:e00455-19. [PMID: 31776237 DOI: 10.1128/mSphere.00455-19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
239 Gening ML, Kurbatova EA, Nifantiev NE. Synthetic Analogs of Streptococcus pneumoniae Capsular Polysaccharides and Immunogenic Activities of Glycoconjugates. Russ J Bioorg Chem 2021;47:1-25. [PMID: 33776393 DOI: 10.1134/S1068162021010076] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Cornick JE, Chaguza C, Harris SR, Yalcin F, Senghore M, Kiran AM, Govindpershad S, Ousmane S, Plessis MD, Pluschke G, Ebruke C, McGee L, Sigaùque B, Collard JM, Antonio M, von Gottberg A, French N, Klugman KP, Heyderman RS, Bentley SD, Everett DB, For The PAGe Consortium. Region-specific diversification of the highly virulent serotype 1 Streptococcus pneumoniae. Microb Genom 2015;1:e000027. [PMID: 28348812 DOI: 10.1099/mgen.0.000027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
241 Bricio-Moreno L, Chaguza C, Yahya R, Shears RK, Cornick JE, Hokamp K, Yang M, Neill DR, French N, Hinton JCD, Everett DB, Kadioglu A. Lower Density and Shorter Duration of Nasopharyngeal Carriage by Pneumococcal Serotype 1 (ST217) May Explain Its Increased Invasiveness over Other Serotypes. mBio 2020;11:e00814-20. [PMID: 33293378 DOI: 10.1128/mBio.00814-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
242 Vaz M, Meirinhos-soares L, Sousa C, Ramirez M, Melo-cristino J, Lopes J. Serotype discrimination of encapsulated Streptococcus pneumoniae strains by Fourier-transform infrared spectroscopy and chemometrics. Journal of Microbiological Methods 2013;93:102-7. [DOI: 10.1016/j.mimet.2013.02.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
243 Fitzwater SP, Chandran A, Santosham M, Johnson HL. The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine. Pediatric Infectious Disease Journal 2012;31:501-8. [DOI: 10.1097/inf.0b013e31824de9f6] [Cited by in Crossref: 136] [Cited by in F6Publishing: 55] [Article Influence: 15.1] [Reference Citation Analysis]
244 Ko E, Jeong S, Jwa MY, Kim AR, Ha YE, Kim SK, Jeong S, Ahn KB, Seo HS, Yun CH, Han SH. Immune Responses to Irradiated Pneumococcal Whole Cell Vaccine. Vaccines (Basel) 2021;9:405. [PMID: 33921842 DOI: 10.3390/vaccines9040405] [Reference Citation Analysis]
245 Lisboa MP, Khan N, Martin C, Xu FF, Reppe K, Geissner A, Govindan S, Witzenrath M, Pereira CL, Seeberger PH. Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. Proc Natl Acad Sci U S A 2017;114:11063-8. [PMID: 28973947 DOI: 10.1073/pnas.1706875114] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
246 Tashani M, Jayasinghe S, Harboe ZB, Rashid H, Booy R. Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction. World J Clin Pediatr 2016; 5(3): 311-318 [PMID: 27610348 DOI: 10.5409/wjcp.v5.i3.311] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
247 Constenla D, Liu T. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses. Vaccine 2019;37:7547-59. [DOI: 10.1016/j.vaccine.2019.09.084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
248 Cornick JE, Everett DB, Broughton C, Denis BB, Banda DL, Carrol ED, Parry CM. Invasive Streptococcus pneumoniae in children, Malawi, 2004-2006. Emerg Infect Dis 2011;17:1107-9. [PMID: 21749782 DOI: 10.3201/eid/1706.101404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
249 Pomat WS, van den Biggelaar AHJ, Wana S, Francis JP, Solomon V, Greenhill AR, Ford R, Orami T, Passey M, Jacoby P, Kirkham LA, Lehmann D, Richmond PC; 10v13v PCV Trial Team. Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants. Clin Infect Dis 2019;68:1472-81. [PMID: 30184183 DOI: 10.1093/cid/ciy743] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
250 Garcia Quesada M, Yang Y, Bennett JC, Hayford K, Zeger SL, Feikin DR, Peterson ME, Cohen AL, Almeida SCG, Ampofo K, Ang M, Bar-Zeev N, Bruce MG, Camilli R, Chanto Chacón G, Ciruela P, Cohen C, Corcoran M, Dagan R, De Wals P, Desmet S, Diawara I, Gierke R, Guevara M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kleynhans J, Kristinsson KG, Ladhani SN, McGeer A, Mwenda JM, Nuorti JP, Oishi K, Ricketson LJ, Sanz JC, Savrasova L, Setchanova LP, Smith A, Valentiner-Branth P, Valenzuela MT, van der Linden M, van Sorge NM, Varon E, Winje BA, Yildirim I, Zintgraff J, Knoll MD, The Pserenade Team. Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project. Microorganisms 2021;9:738. [PMID: 33916227 DOI: 10.3390/microorganisms9040738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Alqahtani AS, Tashani M, Ridda I, Gamil A, Booy R, Rashid H. Burden of clinical infections due to S. pneumoniae during Hajj: A systematic review. Vaccine. 2018;36:4440-4446. [PMID: 29935859 DOI: 10.1016/j.vaccine.2018.04.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
252 Valéa I, Adjei S, Usuf E, Traore O, Ansong D, Tinto H, Owusu Boateng H, Leach A, Mwinessobaonfou Some A, Buabeng P, Vekemans J, Nana LA, Kotey A, Vandoolaeghe P, Ouedraogo F, Sambian D, Lievens M, Tahita MC, Rettig T, Jongert E, Lompo P, Idriss A, Borys D, Ouedraogo S, Prempeh F, Habib MA, Schuerman L, Sorgho H, Agbenyega T. Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial. Hum Vaccin Immunother 2018;14:1489-500. [PMID: 29630438 DOI: 10.1080/21645515.2018.1442996] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
253 González R, Armadans L, Martínez X, Moraga F, Campins M. [Pneumococcal vaccination coverage in at-risk children in Catalonia]. Enferm Infecc Microbiol Clin 2015;33:597-602. [PMID: 25703208 DOI: 10.1016/j.eimc.2015.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
254 Wang X, Cong Z, Huang W, Li C. Molecular characterization of Streptococcus pneumoniae isolated from pediatric patients in Shanghai, China. Pediatr Pulmonol 2020;55:2135-41. [PMID: 32470194 DOI: 10.1002/ppul.24877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
255 Shiragami M, Mizukami A, Leeuwenkamp O, Mrkvan T, Delgleize E, Kurono Y, Iwata S. Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children. Infect Dis Ther 2014. [PMID: 25527448 DOI: 10.1007/s40121-014-0053-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
256 Lee H, Choi EH, Lee HJ. Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines. Korean J Pediatr 2014;57:55-66. [PMID: 24678328 DOI: 10.3345/kjp.2014.57.2.55] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
257 Li L, Fu J, Li S, Guo D, Chen Z, Chen S, Ye X. Phenotypic and molecular characterization of Streptococcus pneumoniae in pre-conjugate vaccine era: A Chinese hospital-based retrospective study. Vaccine 2018;36:599-605. [PMID: 29289385 DOI: 10.1016/j.vaccine.2017.12.063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
258 Dhoubhadel BG, Yasunami M, Yoshida LM, Thi HAN, Thi THV, Thi TAN, Watanabe K, Suzuki M, Morimoto K, Dang DA, Ariyoshi K. A novel high-throughput method for molecular serotyping and serotype-specific quantification of Streptococcus pneumoniae using a nanofluidic real-time PCR system. J Med Microbiol 2014;63:528-39. [PMID: 24464695 DOI: 10.1099/jmm.0.071464-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
259 Wahl B, O'Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, Lukšić I, Nair H, McAllister DA, Campbell H, Rudan I, Black R, Knoll MD. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health 2018;6:e744-57. [PMID: 29903376 DOI: 10.1016/S2214-109X(18)30247-X] [Cited by in Crossref: 338] [Cited by in F6Publishing: 196] [Article Influence: 169.0] [Reference Citation Analysis]
260 Lessa FC, Milucky J, Rouphael NG, Bennett NM, Talbot HK, Harrison LH, Farley MM, Walston J, Pimenta F, Gertz RE, Rajam G, Carvalho MDG, Beall B, Whitney CG. Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule. Sci Rep 2018;8:17959. [PMID: 30568178 DOI: 10.1038/s41598-018-35921-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
261 Seeberger PH. Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach. Chem Rev 2021;121:3598-626. [PMID: 33794090 DOI: 10.1021/acs.chemrev.0c01210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
262 Scott JR, Hanage WP, Lipsitch M, Millar EV, Moulton LH, Hinds J, Reid R, Santosham M, O’brien KL. Pneumococcal sequence type replacement among American Indian children: A comparison of pre- and routine-PCV7 eras. Vaccine 2012;30:2376-81. [DOI: 10.1016/j.vaccine.2011.11.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
263 Mezones-holguin E, Canelo-aybar C, Clark AD, Janusz CB, Jaúregui B, Escobedo-palza S, Hernandez AV, Vega-porras D, González M, Fiestas F, Toledo W, Michel F, Suárez VJ. Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru. Vaccine 2015;33:A154-66. [DOI: 10.1016/j.vaccine.2014.12.039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
264 Mitsuwan W, Olaya-Abril A, Calderón-Santiago M, Jiménez-Munguía I, González-Reyes JA, Priego-Capote F, Voravuthikunchai SP, Rodríguez-Ortega MJ. Integrated proteomic and metabolomic analysis reveals that rhodomyrtone reduces the capsule in Streptococcus pneumoniae. Sci Rep 2017;7:2715. [PMID: 28578394 DOI: 10.1038/s41598-017-02996-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
265 Rudan I, O'Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, Lukšić I, Fischer Walker CL, Black RE, Campbell H; Child Health Epidemiology Reference Group (CHERG). Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 2013;3:010401. [PMID: 23826505 DOI: 10.7189/jogh.03.010401] [Cited by in F6Publishing: 212] [Reference Citation Analysis]
266 Wu X, Jacobs NT, Bozio C, Palm P, Lattar SM, Hanke CR, Watson DM, Sakai F, Levin BR, Klugman KP, Vidal JE. Competitive Dominance within Biofilm Consortia Regulates the Relative Distribution of Pneumococcal Nasopharyngeal Density. Appl Environ Microbiol 2017;83:e00953-17. [PMID: 28576759 DOI: 10.1128/AEM.00953-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
267 Hassane M, Demon D, Soulard D, Fontaine J, Keller LE, Patin EC, Porte R, Prinz I, Ryffel B, Kadioglu A, Veening JW, Sirard JC, Faveeuw C, Lamkanfi M, Trottein F, Paget C. Neutrophilic NLRP3 inflammasome-dependent IL-1β secretion regulates the γδT17 cell response in respiratory bacterial infections. Mucosal Immunol 2017;10:1056-68. [PMID: 28051086 DOI: 10.1038/mi.2016.113] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
268 Wing R, Dor MR, McQuilkin PA. Fever in the pediatric patient. Emerg Med Clin North Am 2013;31:1073-96. [PMID: 24176480 DOI: 10.1016/j.emc.2013.07.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
269 Jiménez-Munguía I, Calderón-Santiago M, Rodríguez-Franco A, Priego-Capote F, Rodríguez-Ortega MJ. Multi-omic profiling to assess the effect of iron starvation in Streptococcus pneumoniae TIGR4. PeerJ 2018;6:e4966. [PMID: 29915696 DOI: 10.7717/peerj.4966] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
270 Chaguza C, Yang M, Cornick JE, du Plessis M, Gladstone RA, Kwambana-Adams BA, Lo SW, Ebruke C, Tonkin-Hill G, Peno C, Senghore M, Obaro SK, Ousmane S, Pluschke G, Collard JM, Sigaùque B, French N, Klugman KP, Heyderman RS, McGee L, Antonio M, Breiman RF, von Gottberg A, Everett DB, Kadioglu A, Bentley SD. Bacterial genome-wide association study of hyper-virulent pneumococcal serotype 1 identifies genetic variation associated with neurotropism. Commun Biol 2020;3:559. [PMID: 33033372 DOI: 10.1038/s42003-020-01290-9] [Reference Citation Analysis]
271 Mehr S, Wood N. Streptococcus pneumoniae--a review of carriage, infection, serotype replacement and vaccination. Paediatr Respir Rev. 2012;13:258-264. [PMID: 23069126 DOI: 10.1016/j.prrv.2011.12.001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 10.0] [Reference Citation Analysis]
272 Dotres CP, Puga R, Ricardo Y, Broño CR, Paredes B, Echemendía V, Rosell S, González N, García-rivera D, Valdés Y, Goldblatt D, Vérez-bencomo V. Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial. Vaccine 2014;32:5266-70. [DOI: 10.1016/j.vaccine.2014.06.094] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
273 Saxena S, Atchison C, Cecil E, Sharland M, Koshy E, Bottle A. Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England. J Infect 2015;71:428-36. [PMID: 26159503 DOI: 10.1016/j.jinf.2015.06.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
274 Kumar R, Arora N, Santosham M. South Asia symposium on pneumococcal disease and the promise of vaccines - Meeting report. Vaccine 2016;34:2622-6. [PMID: 27026150 DOI: 10.1016/j.vaccine.2016.03.071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
275 Pereira CL, Geissner A, Anish C, Seeberger PH. Chemical Synthesis Elucidates the Immunological Importance of a Pyruvate Modification in the Capsular Polysaccharide of Streptococcus pneumoniae Serotype 4. Angew Chem Int Ed 2015;54:10016-9. [DOI: 10.1002/anie.201504847] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
276 Manoharan A, Manchanda V, Balasubramanian S, Lalwani S, Modak M, Bai S, Vijayan A, Shet A, Nagaraj S, Karande S, Nataraj G, Yewale VN, Joshi SA, Iyer RN, Santosham M, Kahn GD, Knoll MD; Alliance for Surveillance of Invasive Pneumococci (ASIP) Study Group. Invasive pneumococcal disease in children aged younger than 5 years in India: a surveillance study. Lancet Infect Dis 2017;17:305-12. [PMID: 27956163 DOI: 10.1016/S1473-3099(16)30466-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
277 Balasubramanian S, Singh P, Dhanalakshmi K, Putlibai S, Varghese R. Clinico-microbiological profile of invasive pneumococcal disease amongst hospitalised children in South India. Indian J Med Microbiol 2019;37:598-9. [PMID: 32436889 DOI: 10.4103/ijmm.IJMM_20_135] [Reference Citation Analysis]
278 Tomczyk S, Lessa FC, Sánchez J, Peña C, Fernández J, Gloria Carvalho M, Pimenta F, Cedano D, Whitney CG, Verani JR, Coradin H, Garib Z, De Oliveira LH, Feris-Iglesias J. Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic. BMC Infect Dis 2018;18:152. [PMID: 29609548 DOI: 10.1186/s12879-018-3047-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
279 Donkor ES, Adegbola RA, Wren BW, Antonio M. Population biology of Streptococcus pneumoniae in West Africa: multilocus sequence typing of serotypes that exhibit different predisposition to invasive disease and carriage. PLoS One 2013;8:e53925. [PMID: 23342041 DOI: 10.1371/journal.pone.0053925] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
280 Aliberti S, Mantero M, Mirsaeidi M, Blasi F. The role of vaccination in preventing pneumococcal disease in adults. Clin Microbiol Infect 2014;20 Suppl 5:52-8. [PMID: 24410778 DOI: 10.1111/1469-0691.12518] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
281 Sundaram N, Chen C, Yoong J, Luvsan ME, Fox K, Sarankhuu A, La Vincente S, Jit M. Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia. Vaccine 2017;35:1055-63. [PMID: 28109706 DOI: 10.1016/j.vaccine.2016.12.070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
282 Liu H, Wang H, Huang M, Mei Y, Gu B, Wu R, Huang Y, Chen Y, Xu Y, Wang T. Analysis of antimicrobial resistance and class 1 integrons among strains from upper respiratory tract of healthy adults. J Thorac Dis 2013;5:149-55. [PMID: 23585941 DOI: 10.3978/j.issn.2072-1439.2013.03.09] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
283 Karki G, Kumar Mandal P. Synthetic directions towards capsular polysaccharide of Streptococcus pneumoniae serotype 18C. Tetrahedron Letters 2019;60:151153. [DOI: 10.1016/j.tetlet.2019.151153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
284 Goettler D, Streng A, Kemmling D, Schoen C, von Kries R, Rose MA, van der Linden M, Liese JG. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany. Vaccine 2020;38:570-7. [PMID: 31735502 DOI: 10.1016/j.vaccine.2019.10.056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
285 Vojtek I, Buchy P, Doherty TM, Hoet B. Would immunization be the same without cross-reactivity? Vaccine 2019;37:539-49. [PMID: 30591255 DOI: 10.1016/j.vaccine.2018.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
286 Samaras JJ, Mauri M, Kay EJ, Wren BW, Micheletti M. Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli. Microb Cell Fact 2021;20:104. [PMID: 34030723 DOI: 10.1186/s12934-021-01588-1] [Reference Citation Analysis]
287 Cornick JE, Tastan Bishop Ö, Yalcin F, Kiran AM, Kumwenda B, Chaguza C, Govindpershad S, Ousmane S, Senghore M, du Plessis M, Pluschke G, Ebruke C, McGee L, Sigaùque B, Collard JM, Bentley SD, Kadioglu A, Antonio M, von Gottberg A, French N, Klugman KP, Heyderman RS, Alderson M, Everett DB; PAGe consortium. The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1. Vaccine 2017;35:972-80. [PMID: 28081968 DOI: 10.1016/j.vaccine.2016.12.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
288 Vila-corcoles A, Ochoa-gondar O, Guzman-avalos A, Gomez-bertomeu F, Figuerola-massana E, Raga-luria X, de Diego-cabanes C, Gutierrez-perez A, Vila-rovira A, Rodriguez-fernandez M. Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002–2009. Infection 2013;41:439-46. [DOI: 10.1007/s15010-012-0345-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
289 Temple B, Toan NT, Dai VTT, Bright K, Licciardi PV, Marimla RA, Nguyen CD, Uyen DY, Balloch A, Huu TN, Mulholland EK. Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial. Lancet Infect Dis 2019;19:497-509. [PMID: 30975525 DOI: 10.1016/S1473-3099(18)30734-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
290 Jauneikaite E, Tocheva AS, Jefferies JM, Gladstone RA, Faust SN, Christodoulides M, Hibberd ML, Clarke SC. Current methods for capsular typing of Streptococcus pneumoniae. J Microbiol Methods 2015;113:41-9. [PMID: 25819558 DOI: 10.1016/j.mimet.2015.03.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
291 Dagan R, Patterson S, Juergens C, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis 2013;57:952-62. [PMID: 23804191 DOI: 10.1093/cid/cit428] [Cited by in Crossref: 146] [Cited by in F6Publishing: 130] [Article Influence: 18.3] [Reference Citation Analysis]
292 Habib M, Porter BD, Satzke C. Capsular serotyping of Streptococcus pneumoniae using the Quellung reaction. J Vis Exp 2014;:e51208. [PMID: 24637727 DOI: 10.3791/51208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
293 Komakhidze T, Hoestlandt C, Dolakidze T, Shakhnazarova M, Chlikadze R, Kopaleishvili N, Goginashvili K, Kherkheulidze M, Clark A, Blau J. Cost-effectiveness of pneumococcal conjugate vaccination in Georgia. Vaccine 2015;33:A219-26. [DOI: 10.1016/j.vaccine.2014.12.070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
294 Plosker GL. 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine: A Review in Infants and Children. Pediatr Drugs 2014;16:425-44. [DOI: 10.1007/s40272-014-0089-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
295 van de Beek D, Brouwer M, Hasbun R, Koedel U, Whitney CG, Wijdicks E. Community-acquired bacterial meningitis. Nat Rev Dis Primers 2016;2. [DOI: 10.1038/nrdp.2016.74] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 17.0] [Reference Citation Analysis]
296 Chen Y, Deng W, Wang SM, Mo QM, Jia H, Wang Q, Li SG, Li X, Yao BD, Liu CJ, Zhan YQ, Ji C, Lopez AL, Wang XY. Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature review. PLoS One 2011;6:e27333. [PMID: 22110628 DOI: 10.1371/journal.pone.0027333] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
297 Edouard S, Al-Tawfiq JA, Memish ZA, Yezli S, Gautret P. Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines. Vaccine 2018;36:7415-22. [PMID: 30236632 DOI: 10.1016/j.vaccine.2018.09.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
298 Capeding MR, Bravo L, Santos J, Kilgore PE, Kim SA, Balter I, Hubler R, Ye J, Moscariello M. Prospective surveillance study of invasive pneumococcal disease among urban children in the Philippines. Pediatr Infect Dis J 2013;32:e383-9. [PMID: 23629024 DOI: 10.1097/INF.0b013e318298dfd5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
299 Licciardi PV, Temple B, Dai VTT, Toan NT, Uyen D, Nguyen CD, Phan TV, Bright K, Marimla RA, Balloch A, Huu TN, Mulholland K. Immunogenicity of alternative ten-valent pneumococcal conjugate vaccine schedules in infants in Ho Chi Minh City, Vietnam: results from a single-blind, parallel-group, open-label, randomised, controlled trial. Lancet Infect Dis 2021:S1473-3099(20)30775-1. [PMID: 34171233 DOI: 10.1016/S1473-3099(20)30775-1] [Reference Citation Analysis]
300 Linares-Pérez N, Toledo-Romaní ME, Santana-Mederos D, García-Fariñas A, García-Rivera D, Valdés-Balbín Y, Vérez-Bencomo V. From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy. Int J Infect Dis 2017;60:98-102. [PMID: 28457742 DOI: 10.1016/j.ijid.2017.03.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
301 Klugman K, Madhi S, Adegbola R, Cutts F, Greenwood B, Hausdorff W. Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose. Vaccine 2011;29:3372-3. [DOI: 10.1016/j.vaccine.2011.02.089] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
302 Ciapponi A, Lee A, Bardach A, Glujovsky D, Rey-ares L, Luisa Cafferata M, Valanzasca P, García Martí S. Interchangeability between Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-Analysis. Value in Health Regional Issues 2016;11:24-34. [DOI: 10.1016/j.vhri.2015.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
303 von Mollendorf C, Cohen C, Tempia S, Meiring S, de Gouveia L, Quan V, Lengana S, Karstaedt A, Dawood H, Seetharam S, Lekalakala R, Madhi SA, Klugman KP, von Gottberg A; Group for Enteric, Respiratory, and Meningeal Disease Surveillance in South Africa (GERMS-SA). Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013. Emerg Infect Dis 2016;22:261-70. [PMID: 26812214 DOI: 10.3201/eid2202.150967] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
304 Indian Academy of Pediatrics Committee on Immunization (IAPCOI). Consensus recommendations on immunization and IAP immunization timetable 2012. Indian Pediatr 2012;49:549-64. [PMID: 22885436 DOI: 10.1007/s13312-012-0116-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
305 Glennie SJ, Banda D, Gould K, Hinds J, Kamngona A, Everett DD, Williams NA, Heyderman RS. Defective pneumococcal-specific Th1 responses in HIV-infected adults precedes a loss of control of pneumococcal colonization. Clin Infect Dis 2013;56:291-9. [PMID: 23024291 DOI: 10.1093/cid/cis842] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
306 Wagenvoort GH, Sanders EA, de Melker HE, van der Ende A, Vlaminckx BJ, Knol MJ. Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia. Vaccine 2017;35:1749-57. [PMID: 28262334 DOI: 10.1016/j.vaccine.2017.02.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
307 Carter ED, Tam Y, Walker N. Impact of vaccination delay on deaths averted by pneumococcal conjugate vaccine: Modeled effects in 8 country scenarios. Vaccine 2019;37:5242-9. [PMID: 31375441 DOI: 10.1016/j.vaccine.2019.07.063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
308 Chaguza C, Cornick JE, Andam CP, Gladstone RA, Alaerts M, Musicha P, Peno C, Bar-Zeev N, Kamng'ona AW, Kiran AM, Msefula CL, McGee L, Breiman RF, Kadioglu A, French N, Heyderman RS, Hanage WP, Bentley SD, Everett DB. Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi. Vaccine 2017;35:4594-602. [PMID: 28711389 DOI: 10.1016/j.vaccine.2017.07.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
309 Hadjipanayis A, Efstathiou E, Alexandrou M, Panayiotou L, Zachariadou C, Petrou P, Papaevangelou V. Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines. PLoS One 2016;11:e0163269. [PMID: 27706247 DOI: 10.1371/journal.pone.0163269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
310 Jallow S, Madhi SA, Madimabe R, Sipambo N, Violari A, Kala U, Petersen K, Naidoo S, Verwey C, Moore DP, Nunes MC. Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions. Vaccine 2017;35:4321-9. [PMID: 28688781 DOI: 10.1016/j.vaccine.2017.06.081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
311 Lindstrand A, Kalyango J, Alfvén T, Darenberg J, Kadobera D, Bwanga F, Peterson S, Henriques-Normark B, Källander K. Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate? PLoS One 2016;11:e0166018. [PMID: 27829063 DOI: 10.1371/journal.pone.0166018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
312 Kaushal N, Kumari S, Jhelum H, Sehgal D. In vitro and in vivo characterization of the interaction, proinflammatory, immunomodulatory and antigenic properties of capsular polysaccharide from Streptococcus pneumoniae serotype 1. Int J Biol Macromol 2020;143:521-32. [PMID: 31816377 DOI: 10.1016/j.ijbiomac.2019.12.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 López-Sanguos C, Rivero Calle I, Rodriguez Tenreiro C, Raguindin PF, Martinón-Torres F. Safety and immunogenicity of pneumococcal conjugate vaccines in preterm infants. Expert Opin Drug Saf 2019;18:253-9. [PMID: 30907170 DOI: 10.1080/14740338.2019.1597849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Everett DB, Cornick J, Denis B, Chewapreecha C, Croucher N, Harris S, Parkhill J, Gordon S, Carrol ED, French N, Heyderman RS, Bentley SD. Genetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a high-throughput whole genome sequencing approach. PLoS One 2012;7:e44250. [PMID: 22970189 DOI: 10.1371/journal.pone.0044250] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
315 Raymond F, Boucher N, Allary R, Robitaille L, Lefebvre B, Tremblay C, Corbeil J, Gervaix A. Serotyping of Streptococcus pneumoniae based on capsular genes polymorphisms. PLoS One 2013;8:e76197. [PMID: 24086706 DOI: 10.1371/journal.pone.0076197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
316 Madhi SA, Govender N, Dayal K, Devadiga R, Van Dyke MK, van Niekerk N, Cutland CL, Adrian PV, Nunes MC. Bacterial and Respiratory Viral Interactions in the Etiology of Acute Otitis Media in HIV-infected and HIV-uninfected South African Children. Pediatr Infect Dis J 2015;34:753-60. [PMID: 25923426 DOI: 10.1097/INF.0000000000000733] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]